parent_id,parent_name,child_id,child_name,parent_smiles,child_smiles,origin,source,tanimoto,set
DB00169,Cholecalciferol,DB00136,Calcitriol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,DB00169,DrugBank Augmented,0.6363636363636364,train
DB00318,Codeine,DB06409,Morphine glucuronide,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,DB00318,DrugBank Augmented,0.5205479452054794,train
DB01420,Testosterone propionate,DB01536,Androstenedione,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented,0.5471698113207547,train
DB00780,Phenelzine,DB09269,Phenylacetic acid,NNCCc1ccccc1,O=C(O)Cc1ccccc1,DB00780,DrugBank Augmented,0.3333333333333333,train
DB15566,Prednisolone acetate,DB00635,Prednisone,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented,0.5373134328358209,train
DB15465,Benzhydrocodone,DB00327,Hydromorphone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,DB15465,DrugBank Augmented,0.4722222222222222,train
DB09419,Xylose,DB03947,D-Xylulose,O=CC(O)C(O)C(O)CO,O=C(CO)C(O)C(O)CO,DB09419,DrugBank Augmented,0.3461538461538461,train
DB13854,Gamolenic acid,DB04557,Arachidonic Acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.9230769230769232,train
DB00154,Dihomo-gamma-linolenic acid,DB00917,Dinoprostone,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,DB00154,DrugBank Augmented,0.3888888888888889,train
DB08908,Dimethyl fumarate,DB01677,Fumaric acid,COC(=O)C=CC(=O)OC,O=C(O)C=CC(=O)O,DB08908,DrugBank Augmented,0.2941176470588235,train
DB00169,Cholecalciferol,DBMET00575,Calcitroic acid,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CC(=O)O)CC(O)CC1O,DB00169,DrugBank Augmented,0.5671641791044776,train
DB00158,Folic acid,DBMET02316,"5,10-methylene tetrahydrofolate (THF)",Nc1nc(=O)c2nc(CNc3ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,N=c1nc(O)c2c([nH]1)NCC1CN(c3ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc3)CN21,DB00158,DrugBank Augmented,0.3563218390804598,train
DB12532,Oxetacaine,DBMET02227,p-hydroxyphentermine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1,CC(C)(N)Cc1ccc(O)cc1,DB12532,DrugBank Augmented,0.2444444444444444,train
DB12532,Oxetacaine,DBMET02228,N-hydroxyphentermine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1,CC(C)(Cc1ccccc1)NO,DB12532,DrugBank Augmented,0.3571428571428571,train
DB00201,Caffeine,DBMET00271,1-Methylxanthine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c2nc[nH]c2c1=O,DB00201,DrugBank Augmented,0.275,train
DB00829,Diazepam,DBMET00650,Oxazepam glucuronide,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,O=C(O)C1OC(OC2N=C(c3ccccc3)c3cc(Cl)ccc3N=C2O)C(O)C(O)C1O,DB00829,DrugBank Augmented,0.2777777777777778,train
DB00795,Sulfasalazine,DBMET00924,N-acetyl-5-ASA (Ac-5-ASA),O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,CC(=O)Nc1ccc(O)c(C(=O)O)c1,DB00795,DrugBank Augmented,0.3148148148148148,train
DB00201,Caffeine,DBMET00272,3-methylxanthine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c(=O)c2[nH]cnc21,DB00201,DrugBank Augmented,0.275,train
DB00201,Caffeine,DBMET00326,"1,3-dimethyluric acid",Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)c2[nH]c(=O)[nH]c2n(C)c1=O,DB00201,DrugBank Augmented,0.3055555555555556,train
DB00285,Venlafaxine,DBMET00437,"N,O-Didesmethylvenlafaxine",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented,0.4565217391304347,train
DB00285,Venlafaxine,DBMET00967,O-Desmethylvenlafaxine glucuronide,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,NCC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented,0.3770491803278688,train
DB03783,Phenacetin,DBMET00580,Acetaminophen glucuronide,CCOc1ccc(NC(C)=O)cc1,CC(=O)Nc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1,DB03783,DrugBank Augmented,0.4090909090909091,train
DB03783,Phenacetin,DBMET00653,Acetaminophen sulfate,CCOc1ccc(NC(C)=O)cc1,CC(=O)Nc1ccc(OS(=O)(=O)O)cc1,DB03783,DrugBank Augmented,0.5454545454545454,train
DB03783,Phenacetin,DBMET00243,NAPQI,CCOc1ccc(NC(C)=O)cc1,CC(=O)N=C1C=CC(=O)C=C1,DB03783,DrugBank Augmented,0.2162162162162162,train
DB00321,Amitriptyline,DBMET00052,E-10-Hydroxynortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CNCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented,0.4042553191489361,train
DB00321,Amitriptyline,DBMET00053,Desmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CCc2ccccc21,DB00321,DrugBank Augmented,0.6176470588235294,train
DB15465,Benzhydrocodone,DBMET00866,Hydromorphone-3-glucuronide,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(=O)CCC3C1C5,DB15465,DrugBank Augmented,0.4642857142857143,train
DB15465,Benzhydrocodone,DBMET00179,Norhydromorphone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,O=C1CCC2C3Cc4ccc(O)c5c4C2(CCN3)C1O5,DB15465,DrugBank Augmented,0.2875,train
DB01420,Testosterone propionate,DBMET01762,2alpha-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,DB01420,DrugBank Augmented,0.4590163934426229,train
DB01420,Testosterone propionate,DBMET01764,15alpha-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,DB01420,DrugBank Augmented,0.5344827586206896,train
DB01420,Testosterone propionate,DBMET01766,16alpha-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,DB01420,DrugBank Augmented,0.6111111111111112,train
DB01420,Testosterone propionate,DBMET00556,Testosterone sulfate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,DB01420,DrugBank Augmented,0.6785714285714286,train
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented,0.3125,train
DB01420,Testosterone propionate,DBMET02835,1β-hydroxy-testosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4=CC(=O)CC(O)C43C)C1CCC2O,DB01420,DrugBank Augmented,0.4426229508196721,train
DB01420,Testosterone propionate,DBMET00562,Testosterone glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,DB01420,DrugBank Augmented,0.5909090909090909,train
DB01420,Testosterone propionate,DBMET02837,11β-hydroxy-testosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C(O)CCC12,DB01420,DrugBank Augmented,0.4833333333333333,train
DB01420,Testosterone propionate,DBMET00571,5-alpha-Dihydrotestosterone glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,DB01420,DrugBank Augmented,0.3246753246753247,train
DB01420,Testosterone propionate,DBMET00392,6-beta-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,DB01420,DrugBank Augmented,0.4354838709677419,train
DB01420,Testosterone propionate,DBMET02830,5-alpha androstanedione,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented,0.296875,train
DB12911,Nicoboxil,DBMET02629,Niacinamide,CCCCOCCOC(=O)c1cccnc1,NC(=O)c1cccnc1,DB12911,DrugBank Augmented,0.45,train
DB12911,Nicoboxil,DBMET02630,Nicotinuric Acid,CCCCOCCOC(=O)c1cccnc1,O=C(O)CNC(=O)c1cccnc1,DB12911,DrugBank Augmented,0.3829787234042553,train
DB12911,Nicoboxil,DBMET02631,Niacinamide N-oxide,CCCCOCCOC(=O)c1cccnc1,NC(=O)c1ccc[n+]([O-])c1,DB12911,DrugBank Augmented,0.2,train
DB12911,Nicoboxil,DBMET02632,Trigonelline,CCCCOCCOC(=O)c1cccnc1,C[n+]1cccc(C(=O)[O-])c1,DB12911,DrugBank Augmented,0.2244897959183673,train
DB15566,Prednisolone acetate,DBMET02859,"17α,21-dihydroxy-pregnan-1,4,6-trien-3,11,30-trione (M-XVII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented,0.3733333333333333,train
DB15566,Prednisolone acetate,DBMET02860,20α-dihydro-prednisone (M-V),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented,0.4444444444444444,train
DB15566,Prednisolone acetate,DBMET02863,6α-hydroxy-prednisone (M-XIII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented,0.4189189189189189,train
DB00688,Mycophenolate mofetil,DBMET02606,6-O-desmethyl-MPA (DM-MPA),COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)O)C(=O)OC2,DB00688,DrugBank Augmented,0.65625,train
DB00741,Hydrocortisone,DBMET02902,Tetrahydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,CC12CCC(O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB00741,DrugBank Augmented,0.4057971014492754,train
DB00741,Hydrocortisone,DBMET02903,Dihydrocortisol,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB00741,DrugBank Augmented,0.5,train
DB00755,Tretinoin,DBMET03635,13-cis-4-Oxoretinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented,0.7021276595744681,train
DB00755,Tretinoin,DBMET03636,13-cis-Retinoyl-beta-glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,DB00755,DrugBank Augmented,0.6271186440677966,train
DB00795,Sulfasalazine,DBMET03575,5'-hydroxysulfapyridine,O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,Nc1ccc(S(=O)(=O)Nc2ccc(O)cn2)cc1,DB00795,DrugBank Augmented,0.375,train
DB00796,Candesartan cilexetil,DBMET00005,O-Deethylated candesartan,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,O=C(O)c1cccc2nc(O)n(Cc3ccc(-c4ccccc4-c4nn[nH]n4)cc3)c12,DB00796,DrugBank Augmented,0.4222222222222222,train
DB00796,Candesartan cilexetil,DBMET00006,Candesartan N2-glucuronide,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnnn2C2OC(C(=O)O)C(O)C(O)C2O)cc1,DB00796,DrugBank Augmented,0.4554455445544554,train
DB00796,Candesartan cilexetil,DBMET00007,Candesartan O-glucuronide,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,CCOc1nc2cccc(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB00796,DrugBank Augmented,0.5102040816326531,train
DB15566,Prednisolone acetate,DBMET02848,Δ6-prednisolone (M-XI),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented,0.4927536231884058,train
DB15566,Prednisolone acetate,DBMET02849,20α-dihydro-prednisolone (M-III),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented,0.609375,train
DB15566,Prednisolone acetate,DBMET02851,6αhydroxy-prednisolone (M-VII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented,0.5522388059701493,train
DB01408,Bambuterol,DBMET03275,Terbutaline Sulfate,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,DB01408,DrugBank Augmented,0.5121951219512195,train
DB15465,Benzhydrocodone,DBMET00420,norhydrocodone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(=O)CCC4C(C2)NCCC314,DB15465,DrugBank Augmented,0.3947368421052631,train
DB15465,Benzhydrocodone,DBMET02686,6-α-hydrocodol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,DB15465,DrugBank Augmented,0.5588235294117647,train
DB15465,Benzhydrocodone,DBMET02685,6-α-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented,0.4305555555555556,train
DB00755,Tretinoin,DBMET02554,4-hydroxy-13-cis-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented,0.6666666666666666,train
DB01235,Levodopa,DBMET00534,6-Hydroxydopamine,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1cc(O)c(O)cc1O,DB01235,DrugBank Augmented,0.2432432432432432,train
DB01235,Levodopa,DBMET00565,Dopamine 4-sulfate,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(OS(=O)(=O)O)c(O)c1,DB01235,DrugBank Augmented,0.3181818181818182,train
DB01235,Levodopa,DBMET00573,Dopamine 3-O-sulfate,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(O)c(OS(=O)(=O)O)c1,DB01235,DrugBank Augmented,0.3255813953488372,train
DB01235,Levodopa,DBMET00587,Dopamine glucuronide,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(O)c1,DB01235,DrugBank Augmented,0.2727272727272727,train
DB00688,Mycophenolate mofetil,DBMET00767,6-O-desmethyl-mycophenolic acid,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,CC(=CCc1c(O)c(C)c2c(c1O)C(=O)OC2)CCC(=O)O,DB00688,DrugBank Augmented,0.5223880597014925,train
DB00688,Mycophenolate mofetil,DBMET00917,Mycophenolic acid-7-O-glucuronide,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,COc1c(C)c2c(c(OC3OC(C(=O)O)C(O)C(O)C3O)c1CC=C(C)CCC(=O)O)C(=O)OC2,DB00688,DrugBank Augmented,0.4814814814814814,train
DB00688,Mycophenolate mofetil,DBMET00662,Mycophenolic acid-acyl glucuronide,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)OC2,DB00688,DrugBank Augmented,0.5921052631578947,train
DB01039,Fenofibrate,DBMET02797,Fenofibryl Glucuronide,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,DB01039,DrugBank Augmented,0.5185185185185185,train
DB01039,Fenofibrate,DBMET02798,Reduced Fenofibric Acid,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,CC(C)(Oc1ccc(C(O)c2ccc(Cl)cc2)cc1)C(=O)O,DB01039,DrugBank Augmented,0.4888888888888889,train
DB16627,Melphalan flufenamide,DBMET03698,Monohydroxymelphalan,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1,NC(Cc1ccc(N(CCO)CCCl)cc1)C(=O)O,DB16627,DrugBank Augmented,0.4912280701754385,train
DB16627,Melphalan flufenamide,DBMET03699,,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1,NC(Cc1ccc(N(CCO)CCO)cc1)C(=O)O,DB16627,DrugBank Augmented,0.4035087719298245,train
DB01086,Benzocaine,DBMET03290,4-Acetaminobenzoic acid,CCOC(=O)c1ccc(N)cc1,CC(=O)Nc1ccc(C(=O)O)cc1,DB01086,DrugBank Augmented,0.2571428571428571,train
DB01235,Levodopa,DBMET02451,Dopamine-3-O-glucuronide,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(O)c(OC2OC(C(=O)O)C(O)C(O)C2O)c1,DB01235,DrugBank Augmented,0.2830188679245283,train
DB01235,Levodopa,DBMET02440,3-Methoxytyramine,NC(Cc1ccc(O)c(O)c1)C(=O)O,COc1cc(CCN)ccc1O,DB01235,DrugBank Augmented,0.2926829268292683,train
DB01235,Levodopa,DBMET02445,"3,4-Dihydroxyphenylacetaldehyde (DOPAL)",NC(Cc1ccc(O)c(O)c1)C(=O)O,O=CCc1ccc(O)c(O)c1,DB01235,DrugBank Augmented,0.4545454545454545,train
DB01255,Lisdexamfetamine,DBMET00540,Norephedrine,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(N)C(O)c1ccccc1,DB01255,DrugBank Augmented,0.2666666666666666,train
DB01255,Lisdexamfetamine,DBMET03721,4-Hydroxy-d-amphetamine,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(N)Cc1ccc(O)cc1,DB01255,DrugBank Augmented,0.2888888888888888,train
DB01255,Lisdexamfetamine,DBMET02222,Phenylacetone,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(=O)Cc1ccccc1,DB01255,DrugBank Augmented,0.3023255813953488,train
DB01420,Testosterone propionate,DBMET01585,6beta-hydroxy-androstenedione,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CC(O)C4=CC(=O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented,0.365079365079365,train
DB13854,Gamolenic acid,DBMET01593,5-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC=CC=CC(O)CCCC(=O)O,DB13854,DrugBank Augmented,0.6486486486486487,train
DB13854,Gamolenic acid,DBMET01594,7-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC=CC(O)C=CCCCC(=O)O,DB13854,DrugBank Augmented,0.7058823529411765,train
DB13854,Gamolenic acid,DBMET01595,10-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CC(O)C=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.7272727272727273,train
DB13854,Gamolenic acid,DBMET01596,13-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CC(O)C=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.7058823529411765,train
DB13854,Gamolenic acid,DBMET01597,20-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,O=C(O)CCCC=CCC=CCC=CCC=CCCCCCO,DB13854,DrugBank Augmented,0.6129032258064516,train
DB13854,Gamolenic acid,DBMET01598,19-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CC(O)CCCC=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.5588235294117647,train
DB13854,Gamolenic acid,DBMET01599,18-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCC(O)CCC=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.5714285714285714,train
DB13854,Gamolenic acid,DBMET01600,17-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCC(O)CC=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.5833333333333334,train
DB13854,Gamolenic acid,DBMET01601,16-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCC(O)C=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.6285714285714286,train
DB13854,Gamolenic acid,DBMET01602,"14,15-EET",CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC1OC1CC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.5897435897435898,train
DB13854,Gamolenic acid,DBMET01603,"11,12-EET",CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC1OC1CC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.6857142857142857,train
DB13854,Gamolenic acid,DBMET01604,"8,9-EET",CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC1OC1CC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.6857142857142857,train
DB13854,Gamolenic acid,DBMET01605,"5,6-EET",CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC=CCC1OC1CCCC(=O)O,DB13854,DrugBank Augmented,0.631578947368421,train
DB13854,Gamolenic acid,DBMET01606,15-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC(O)C=CC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.6052631578947368,train
DB13854,Gamolenic acid,DBMET01607,12-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC(O)C=CC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.631578947368421,train
DB13854,Gamolenic acid,DBMET01608,11-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CC=CC(O)CC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.631578947368421,train
DB13854,Gamolenic acid,DBMET01609,9-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC(O)C=CC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.631578947368421,train
DB13854,Gamolenic acid,DBMET01610,8-HETE,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CC=CC(O)CC=CCCCC(=O)O,DB13854,DrugBank Augmented,0.631578947368421,train
DB00285,Venlafaxine,DBMET02409,Benzyl hydroxy desvenlafaxine,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CN(C)CC(c1ccc(O)c(O)c1)C1(O)CCCCC1,DB00285,DrugBank Augmented,0.627906976744186,train
DB00285,Venlafaxine,DBMET02410,Cyclohexane ring hydroxy desvenlafaxine,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CN(C)CC(c1ccc(O)cc1)C1(O)CCC(O)CC1,DB00285,DrugBank Augmented,0.5217391304347826,train
DB00285,Venlafaxine,DBMET02411,Desvenlafaxine O-glucuronide,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CN(C)CC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented,0.5535714285714286,train
DB00285,Venlafaxine,DBMET02412,Desvenlafaxine N-oxide,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,C[N+](C)([O-])CC(c1ccc(O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented,0.4468085106382978,train
DB16629,Serdexmethylphenidate,DBMET02407,p-hydroxy-methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(=O)C(c1ccc(O)cc1)C1CCCCN1,DB16629,DrugBank Augmented,0.2911392405063291,train
DB16629,Serdexmethylphenidate,DBMET02408,6-oxo-methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(=O)C(c1ccccc1)C1CCCC(=O)N1,DB16629,DrugBank Augmented,0.3466666666666667,train
DB16629,Serdexmethylphenidate,DBMET00651,Ritalinic acid,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,O=C(O)C(c1ccccc1)C1CCCCN1,DB16629,DrugBank Augmented,0.2972972972972973,train
DB07565,Chloramphenicol succinate,DBMET03152,Chloramphenicol Sulfate,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(NC(COS(=O)(=O)O)C(O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,DB07565,DrugBank Augmented,0.6481481481481481,train
DB07565,Chloramphenicol succinate,DBMET03158,Chloramphenicol 3-acetate,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,CC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.7254901960784313,train
DB07565,Chloramphenicol succinate,DBMET03161,Chloramphenicol Alcohol,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(CO)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.4727272727272727,train
DB07565,Chloramphenicol succinate,DBMET03162,Chloramphenicol Oxamic Acid,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(O)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.5185185185185185,train
DB07565,Chloramphenicol succinate,DBMET03165,Chloramphenicol Aryl Amine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,Nc1ccc(C(O)C(N)CO)cc1,DB07565,DrugBank Augmented,0.2142857142857142,train
DB07565,Chloramphenicol succinate,DBMET03167,Chloramphenicol Base,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.4150943396226415,train
DB07565,Chloramphenicol succinate,DBMET03169,Chloramphenicol Glucuronide,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(NC(COC1OC(C(=O)O)C(O)C(O)C1O)C(O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,DB07565,DrugBank Augmented,0.5625,train
DB08804,Nandrolone decanoate,DBMET03358,19-Norandrosterone,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,DB08804,DrugBank Augmented,0.2191780821917808,train
DB08804,Nandrolone decanoate,DBMET03359,19-Noretiocholanolone,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,CC12CCC3C4CCC(O)CC4CCC3C1CCC2O,DB08804,DrugBank Augmented,0.2463768115942029,train
DB09042,Tedizolid phosphate,DBMET03123,Tedizolid sulphate,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,Cn1nnc(-c2ccc(-c3ccc(N4CC(C=S(=O)(O)O)OC4=O)cc3F)cn2)n1,DB09042,DrugBank Augmented,0.6666666666666666,train
DB09042,Tedizolid phosphate,DBMET03125,Desmethyl tedizolid,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,O=C1OC(CO)CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,DB09042,DrugBank Augmented,0.6081081081081081,train
DB09042,Tedizolid phosphate,DBMET03126,Carboxy tedizolid,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,Cn1nnc(-c2ccc(-c3ccc(N4CC(C(=O)O)OC4=O)cc3F)cn2)n1,DB09042,DrugBank Augmented,0.7083333333333334,train
DB09042,Tedizolid phosphate,DBMET03127,Ring-opened tedizolid metabolite,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,Cn1nnc(-c2ccc(-c3ccc(NCC(=O)O)cc3F)cn2)n1,DB09042,DrugBank Augmented,0.4743589743589743,train
DB00318,Codeine,DBMET02018,"morphine-3,6-diglucuronide",COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,OC1OC(Oc2ccc3c4c2OC2C(OC5OC(O)C(O)C(O)C5O)C=CC5C(C3)NCCC452)C(O)C(O)C1O,DB00318,DrugBank Augmented,0.3636363636363636,train
DB11660,Latanoprostene bunod,DBMET02014,"1,2 dinor latanoprost acid",O=C(CCCC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1)OCCCCO[N+](=O)[O-],O=C(O)CC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1,DB11660,DrugBank Augmented,0.5757575757575758,train
DB11660,Latanoprostene bunod,DBMET02015,"1,2,3,4-tetranor latanoprost acid",O=C(CCCC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1)OCCCCO[N+](=O)[O-],O=C(O)CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1,DB11660,DrugBank Augmented,0.5076923076923077,train
DB16629,Serdexmethylphenidate,DBMET03284,Ethylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,CCOC(=O)C(c1ccccc1)C1CCCCN1,DB16629,DrugBank Augmented,0.3037974683544304,train
DB00121,Biotin,DBMET03073,Biocytin,O=C(O)CCCCC1SCC2NC(=O)NC21,NC(CCCCCNOC(=O)CCCCC1SCC2NC(=O)NC21)C(=O)O,DB00121,DrugBank Augmented,0.5535714285714286,train
DB00130,L-Glutamine,DBMET03078,α-ketoglutarate,NC(=O)CCC(N)C(=O)O,O=C(O)CCC(=O)C(=O)O,DB00130,DrugBank Augmented,0.2222222222222222,train
DB00153,Ergocalciferol,DBMET02435,Calcitrol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)C=CC(C)C(C)(C)O)CC(O)CC1O,DB00153,DrugBank Augmented,0.6307692307692307,train
DB00158,Folic acid,DBMET00528,5-Methyltetrahydrofolate,Nc1nc(=O)c2nc(CNc3ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1,DB00158,DrugBank Augmented,0.5063291139240507,train
DB00175,Pravastatin,DBMET02470,"5,6-epoxy-3-alpha-isopravastatin",CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,CCC(C)C(=O)OC1CC2OC2C2C=C(O)C(C)C(CCC(O)CC(O)CC(=O)O)C12,DB00175,DrugBank Augmented,0.5256410256410257,train
DB00175,Pravastatin,DBMET02471,7-hydroxy-3-alpha-isopravastatin,CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,CCC(C)C(=O)OC1C(O)CC=C2C=C(O)C(C)C(CCC(O)CC(O)CC(=O)O)C21,DB00175,DrugBank Augmented,0.5333333333333333,train
DB00175,Pravastatin,DBMET02474,"3-keto-5,6-diol pravastatin",CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,CCC(C)C(=O)OC1CC(O)C(O)C2=CC(=O)C(C)C(CCC(O)CC(O)CC(=O)O)C21,DB00175,DrugBank Augmented,0.6111111111111112,train
DB00175,Pravastatin,DBMET02477,3'(S)-hydroxy-pravastatin-tetranor glucuronide,CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,CC(O)C(C)C(=O)OC1CC(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2C=CC(C)C(CCC(O)O)C21,DB00175,DrugBank Augmented,0.4523809523809524,train
DB00175,Pravastatin,DBMET02476,3'(S)-hydroxy-pravastatin-tetranor,CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,CC(O)C(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)O)C21,DB00175,DrugBank Augmented,0.6307692307692307,train
DB00184,Nicotine,DBMET00519,Cotinine,CN1CCCC1c1cccnc1,CN1C(=O)CCC1c1cccnc1,DB00184,DrugBank Augmented,0.5641025641025641,train
DB00184,Nicotine,DBMET00529,Cotinine N-oxide,CN1CCCC1c1cccnc1,CN1C(=O)CCC1c1ccc[n+]([O-])c1,DB00184,DrugBank Augmented,0.2653061224489796,train
DB00184,Nicotine,DBMET00527,3'-Hydroxycotinine,CN1CCCC1c1cccnc1,CN1C(=O)C(O)CC1c1cccnc1,DB00184,DrugBank Augmented,0.5121951219512195,train
DB00184,Nicotine,DBMET00520,Nornicotine,CN1CCCC1c1cccnc1,c1cncc(C2CCCN2)c1,DB00184,DrugBank Augmented,0.4736842105263157,train
DB00184,Nicotine,DBMET00533,Nicotine-1'-N-oxide,CN1CCCC1c1cccnc1,C[N+]1([O-])CCCC1c1cccnc1,DB00184,DrugBank Augmented,0.4878048780487805,train
DB00184,Nicotine,DBMET00517,Cotinine glucuronide,CN1CCCC1c1cccnc1,CN1C(=O)CCC1c1ccc[n+](C2OC(C(=O)[O-])C(O)C(O)C2O)c1,DB00184,DrugBank Augmented,0.2,train
DB12532,Oxetacaine,DBMET02229,Nitrophentermine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1,CC(C)(Cc1ccccc1)[N+](=O)[O-],DB12532,DrugBank Augmented,0.3409090909090909,train
DB00201,Caffeine,DBMET00611,"1,7-Dimethyluric acid",Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c2[nH]c(=O)n(C)c2c1=O,DB00201,DrugBank Augmented,0.2941176470588235,train
DB00201,Caffeine,DBMET00560,1-Methyluric acid,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c2[nH]c(=O)[nH]c2c1=O,DB00201,DrugBank Augmented,0.2051282051282051,train
DB00202,Succinylcholine,DBMET01477,Succinic Acid,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,O=C(O)CCC(=O)O,DB00202,DrugBank Augmented,0.217391304347826,train
DB00202,Succinylcholine,DB00122,Choline,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,C[N+](C)(C)CCO,DB00202,DrugBank Augmented,0.3478260869565217,train
DB00208,Ticlopidine,DBMET01202,Active metabolite of Ticlopidine,Clc1ccccc1CN1CCc2sccc2C1,O=C(O)CC1CN(Cc2ccccc2Cl)CCC1S,DB00208,DrugBank Augmented,0.3636363636363636,train
DB00208,Ticlopidine,DBMET01207,Ticlopidine S-oxide dimer,Clc1ccccc1CN1CCc2sccc2C1,[O-][S+]1C2=C(CN(Cc3ccccc3Cl)CC2)C2C1C1C3=C(CCN(Cc4ccccc4Cl)C3)C2[S+]1[O-],DB00208,DrugBank Augmented,0.4285714285714285,train
DB00208,Ticlopidine,DBMET01208,Thienopyridinium,Clc1ccccc1CN1CCc2sccc2C1,Clc1ccccc1C[n+]1ccc2sccc2c1,DB00208,DrugBank Augmented,0.34,train
DB00208,Ticlopidine,DBMET01209,Ticlopidine lactam analog (M8),Clc1ccccc1CN1CCc2sccc2C1,O=C1c2ccsc2CCN1Cc1ccccc1Cl,DB00208,DrugBank Augmented,0.5434782608695652,train
DB00214,Torasemide,DBMET02230,Torasemide M5,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,CC(C)NC(=O)NS(=O)(=O)c1c[nH]ccc1=Nc1cccc(C(=O)O)c1,DB00214,DrugBank Augmented,0.3661971830985915,train
DB00215,Citalopram,DBMET03705,didemethylcitalopram,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCCN)c1ccc(F)cc1,DB00215,DrugBank Augmented,0.75,train
DB00215,Citalopram,DBMET03706,Citalopram propionic aldehyde,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC=O)c1ccc(F)cc1,DB00215,DrugBank Augmented,0.6727272727272727,train
DB00215,Citalopram,DBMET03707,Citalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB00215,DrugBank Augmented,0.6607142857142857,train
DB00222,Glimepiride,DBMET01327,Cyclohexyl carboxyl glimepiride,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C(=O)O)CC3)cc2)C1=O,DB00222,DrugBank Augmented,0.8461538461538461,train
DB00238,Nevirapine,DBMET00669,12-hydroxynevirapine glucuronide,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,Cc1ccnc2c1N=C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccnc1N2C1CC1O,DB00238,DrugBank Augmented,0.3243243243243243,train
DB00238,Nevirapine,DBMET00727,4-carboxynevirapine,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,O=C1Nc2c(C(=O)O)ccnc2N(C2CC2)c2ncccc21,DB00238,DrugBank Augmented,0.723404255319149,train
DB00238,Nevirapine,DBMET00685,2-hydroxynevirapine glucuronide,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,Cc1cc(OC2OC(C(=O)O)C(O)C(O)C2O)nc2c1N=C(O)c1cccnc1N2C1CC1,DB00238,DrugBank Augmented,0.36,train
DB00238,Nevirapine,DBMET00779,8-hydroxynevirapine glucuronide,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,Cc1ccnc2c1NC(=O)c1cc(OC3OC(C(=O)O)C(O)C(O)C3O)cnc1N2C1CC1,DB00238,DrugBank Augmented,0.5147058823529411,train
DB00238,Nevirapine,DBMET00712,3-hydroxynevirapine glucuronide,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,Cc1c(O)cnc2c1N=C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccnc1N2C1CC1,DB00238,DrugBank Augmented,0.3421052631578947,train
DB00242,Cladribine,DBMET03775,Cladribine diphosphate,Nc1nc(Cl)nc2c1ncn2C1CC(O)C(CO)O1,Nc1nc(Cl)nc2c1ncn2C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1,DB00242,DrugBank Augmented,0.6724137931034483,train
DB00243,Ranolazine,DBMET02255,CVT-3389,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,Cc1ccc(O)c(C)c1NC(=O)CN1CCNCC1,DB00243,DrugBank Augmented,0.3809523809523809,train
DB00243,Ranolazine,DBMET02251,CVT-2537,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,Cc1cccc(C)c1NC(=O)CC(=O)O,DB00243,DrugBank Augmented,0.3703703703703703,train
DB00245,Benzatropine,DBMET02261,N-desmethyl-4'-hydroxy benztropine,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,OC1(OC(c2ccccc2)c2ccccc2)CC2CCC(C1)N2,DB00245,DrugBank Augmented,0.3333333333333333,train
DB00246,Ziprasidone,DBMET02985,Ziprasidone Sulfone,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,O=C1Cc2cc(CCN3CCN(C4=NS(=O)(=O)c5ccccc54)CC3)c(Cl)cc2N1,DB00246,DrugBank Augmented,0.5857142857142857,train
DB00246,Ziprasidone,DBMET02990,"3-(piperazine-1-yl)-1,2-benzisothiazole sulfoxide",O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,[O-][s+]1nc(N2CCNCC2)c2ccccc21,DB00246,DrugBank Augmented,0.2083333333333333,train
DB00246,Ziprasidone,DBMET02994,S-Methyl-dihydro-ziprasidone-sulfoxide,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,C[S+]([O-])c1ccccc1C(=N)N1CCN(CCc2cc3c(cc2Cl)NC(=O)C3)CC1,DB00246,DrugBank Augmented,0.5135135135135135,train
DB00250,Dapsone,DBMET01043,Nitroso-dapsone,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,Nc1ccc(S(=O)(=O)c2ccc(N=O)cc2)cc1,DB00250,DrugBank Augmented,0.6956521739130435,train
DB00261,Anagrelide,DBMET00676,"2-amino-5,6-dichloro-3,4,-dihydroquinazoline",O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1,NC1=NCc2c(ccc(Cl)c2Cl)N1,DB00261,DrugBank Augmented,0.3191489361702128,train
DB00281,Lidocaine,DBMET01090,3-Hydroxymonoethylglycinexylidide,CCN(CC)CC(=O)Nc1c(C)cccc1C,CCNCC(=O)Nc1c(C)ccc(O)c1C,DB00281,DrugBank Augmented,0.3953488372093023,train
DB00281,Lidocaine,DBMET01089,"2,6-Dimethylaniline (2,6-Xylidine)",CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C)c1N,DB00281,DrugBank Augmented,0.2647058823529412,train
DB00281,Lidocaine,DBMET01091,Glycinexylidide (GX),CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C)c1NC(=O)CN,DB00281,DrugBank Augmented,0.5882352941176471,train
DB00281,Lidocaine,DBMET01128,2-Amino-3-methylbenzoate,CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C(=O)O)c1N,DB00281,DrugBank Augmented,0.3,train
DB00285,Venlafaxine,DBMET00958,"N,O-didesmethylvenlafaxine glucuronide",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented,0.3809523809523809,train
DB00289,Atomoxetine,DBMET02294,4-hydroxyatomoxetine-O-glucuronide,CNCCC(Oc1ccccc1C)c1ccccc1,CNCCC(Oc1ccc(O)cc1OC1OC(O)C(O)C(O)C1O)c1ccccc1,DB00289,DrugBank Augmented,0.4727272727272727,train
DB00289,Atomoxetine,DBMET02305,N-desmethyl-4-hydroxyatomoxetine,CNCCC(Oc1ccccc1C)c1ccccc1,Cc1ccccc1OC(CCN)c1ccc(O)cc1,DB00289,DrugBank Augmented,0.5348837209302325,train
DB00296,Ropivacaine,DBMET03534,4-OH-PPX,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Cc1cc(O)cc(C)c1NC(=O)C1CCCCN1,DB00296,DrugBank Augmented,0.3454545454545454,train
DB00296,Ropivacaine,DBMET03535,3-OH-PPX,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Cc1ccc(O)c(C)c1NC(=O)C1CCCCN1,DB00296,DrugBank Augmented,0.3508771929824561,train
DB00300,Tenofovir disoproxil,DBMET01177,Tenofovir Diphosphate,CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C,CC(Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,DB00300,DrugBank Augmented,0.6129032258064516,train
DB00304,Desogestrel,DB00294,Etonogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3C(=C)CC21CC,DB00304,DrugBank Augmented,0.7166666666666667,train
DB00313,Valproic acid,,"2,4-Diene-VPA",CCCC(CCC)C(=O)O,C=CC=C(CCC)C(=O)O,DB00313,DrugBank Augmented,0.2666666666666666,train
DB00313,Valproic acid,DBMET01107,2-n-Propyl-4-oxopentanoic acid,CCCC(CCC)C(=O)O,CCCC(CC(C)=O)C(=O)O,DB00313,DrugBank Augmented,0.6818181818181818,train
DB00313,Valproic acid,DBMET01109,2-Propylglutaric acid,CCCC(CCC)C(=O)O,CCCC(CCC(=O)O)C(=O)O,DB00313,DrugBank Augmented,0.7619047619047619,train
DB00313,Valproic acid,DBMET01110,3-Oxovalproic acid,CCCC(CCC)C(=O)O,CCCC(C(=O)O)C(=O)CC,DB00313,DrugBank Augmented,0.5217391304347826,train
DB00313,Valproic acid,DBMET00062,3-Hydroxyvalproic acid,CCCC(CCC)C(=O)O,CCCC(C(=O)O)C(O)CC,DB00313,DrugBank Augmented,0.48,train
DB00315,Zolmitriptan,DBMET03120,Indole ethyl alcohol zolmitriptan derivative,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,O=C1NC(Cc2ccc3[nH]cc(CCO)c3c2)CO1,DB00315,DrugBank Augmented,0.75,train
DB03783,Phenacetin,DBMET00789,Acetaminophen cysteine,CCOc1ccc(NC(C)=O)cc1,CC(=O)Nc1ccc(SCC(N)C(=O)O)cc1,DB03783,DrugBank Augmented,0.4358974358974359,train
DB00321,Amitriptyline,DBMET00482,E-10-Hydroxydesmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented,0.4,train
DB00349,Clobazam,DBMET03601,4'-hydroxy-N-desmethylclobazam,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,O=C1CC(=O)N(c2ccc(O)cc2)c2cc(Cl)ccc2N1,DB00349,DrugBank Augmented,0.4313725490196078,train
DB00352,Tioguanine,DBMET01154,Thioguanosine diphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3OC(COP(=O)(O)OP(=O)(O)O)C(O)C3O)c2[nH]1,DB00352,DrugBank Augmented,0.2272727272727272,train
DB00363,Clozapine,DBMET03597,Desmethylclozapine glucuronide,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,O=C(O)C1OC(N2c3ccc(Cl)cc3N=C(N3CCNCC3)c3ccccc32)C(O)C(O)C1O,DB00363,DrugBank Augmented,0.3561643835616438,train
DB00384,Triamterene,DBMET02480,4'-OH-triamterene sulfate,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,Nc1nc(N)c2nc(-c3ccc(OS(=O)(=O)O)cc3)c(N)nc2n1,DB00384,DrugBank Augmented,0.5609756097560976,train
DB00394,Beclomethasone dipropionate,DBMET02591,Beclomethasone (BOH),CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO,DB00394,DrugBank Augmented,0.625,train
DB00404,Alprazolam,DBMET02467,"alpha,4-dihydroxy-alprazolam",Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2O,DB00404,DrugBank Augmented,0.4333333333333333,train
DB00404,Alprazolam,DBMET02468,Alprazolam benzophenone metabolite,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,Cc1nnc(CO)n1-c1ccc(Cl)cc1C(=O)c1ccccc1,DB00404,DrugBank Augmented,0.4,train
DB00409,Remoxipride,DBMET03194,Remoxipride Metabolite NCL 118,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1CCC(=O)N1,DB00409,DrugBank Augmented,0.5789473684210527,train
DB00409,Remoxipride,DBMET03195,Remoxipride Metabolite NCM 001,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CCN1C(=O)CCC1(O)CNC(=O)c1c(OC)ccc(Br)c1OC,DB00409,DrugBank Augmented,0.5,train
DB00412,Rosiglitazone,DBMET00936,N-Desmethyl-ortho-hydroxy rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ncccc3O)cc2)S1,DB00412,DrugBank Augmented,0.5573770491803278,train
DB00412,Rosiglitazone,DBMET00938,N-Desmethyl-para-hydroxy rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ccc(O)cn3)cc2)S1,DB00412,DrugBank Augmented,0.492063492063492,train
DB00412,Rosiglitazone,DBMET00968,ortho-O-Glucuronide rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ncccc1OC1OC(C(=O)O)C(O)C(O)C1O,DB00412,DrugBank Augmented,0.5616438356164384,train
DB00412,Rosiglitazone,DBMET00969,ortho-O-Sulfate rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ncccc1OS(=O)(=O)O,DB00412,DrugBank Augmented,0.6507936507936508,train
DB00412,Rosiglitazone,DBMET01111,N-Desmethyl glucuronide rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1N=C(O)C(Cc2ccc(OCCNc3ncccc3OC3OC(C(=O)O)C(O)C(O)C3O)cc2)S1,DB00412,DrugBank Augmented,0.3411764705882353,train
DB00412,Rosiglitazone,DBMET00981,para-O-Glucuronide rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cn1,DB00412,DrugBank Augmented,0.5857142857142857,train
DB00412,Rosiglitazone,DBMET01112,para-O-Sulfate rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccc(OS(=O)(=O)O)cn1,DB00412,DrugBank Augmented,0.6833333333333333,train
DB00421,Spironolactone,DBMET02483,7-alpha-thiomethylspironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,CSC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,DB00421,DrugBank Augmented,0.7857142857142857,train
DB00425,Zolpidem,DBMET01241,Zolpidem carboxylic acid derivative (M2),Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,Cc1ccc(-c2nc3ccc(C(=O)O)cn3c2CC(=O)N(C)C)cc1,DB00425,DrugBank Augmented,0.8,train
DB00425,Zolpidem,DBMET01242,Zolpidem carboxylic acid derivative (M1),Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,Cc1ccc2nc(-c3ccc(C(=O)O)cc3)c(CC(=O)N(C)C)n2c1,DB00425,DrugBank Augmented,0.8636363636363636,train
DB00441,Gemcitabine,DBMET00694,"2′,2′-difluorodeoxyuridine monophosphate",Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1,O=c1ccn(C2OC(COP(=O)(O)O)C(O)C2(F)F)c(=O)[nH]1,DB00441,DrugBank Augmented,0.4406779661016949,train
DB00441,Gemcitabine,DBMET00858,Gemcitabine diphosphate,Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1,Nc1ccn(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)c(=O)n1,DB00441,DrugBank Augmented,0.6666666666666666,train
DB00444,Teniposide,DBMET01263,Teniposide o-quinone derivative,COc1cc(C2c3cc4c(cc3C(OC3OC5COC(c6cccs6)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O,COC1=CC(C2c3cc4c(cc3C(OC3OC5COC(c6cccs6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(=O)C1=O,DB00444,DrugBank Augmented,0.7386363636363636,train
DB00458,Imipramine,DBMET00680,2-hydroxy-imipramine glucuronide,CN(C)CCCN1c2ccccc2CCc2ccccc21,CN(C)CCCN1c2ccccc2CCc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc21,DB00458,DrugBank Augmented,0.5,train
DB00458,Imipramine,DBMET01961,10-hydroxydidemethylimipramine,CN(C)CCCN1c2ccccc2CCc2ccccc21,NCCCN1c2ccccc2CC(O)c2ccccc21,DB00458,DrugBank Augmented,0.391304347826087,train
DB01151,Desipramine,DBMET01956,2-hydroxydesipramine glucuronide,CNCCCN1c2ccccc2CCc2ccccc21,CNCCCN1c2ccccc2CCc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc21,DB01151,DrugBank Augmented,0.5087719298245614,train
DB00461,Nabumetone,DBMET02530,reduced 3-hydroxy-nabumetone,COc1ccc2cc(CCC(C)=O)ccc2c1,COc1ccc2cc(CC(O)C(C)O)ccc2c1,DB00461,DrugBank Augmented,0.5,train
DB00461,Nabumetone,DBMET02534,O-desmethyl-3-hydroxy-nabumetone,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(=O)C(O)Cc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented,0.3636363636363636,train
DB00461,Nabumetone,DBMET02536,4-(6-Methoxy-2-naphthyl)- butan-2-ol glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,COc1ccc2cc(CCC(C)OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.4363636363636363,train
DB00461,Nabumetone,DBMET02537,4-(6-hydroxy-2-naphthyl)- butan-2-ol,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented,0.3488372093023256,train
DB00461,Nabumetone,DBMET02545,4-(6-Hydroxy-2-naphthyl)- butan-2-one glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(=O)CCc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.5306122448979592,train
DB00461,Nabumetone,DBMET00764,6-methoxy-2-naphthylacetic acid,COc1ccc2cc(CCC(C)=O)ccc2c1,COc1ccc2cc(CC(=O)O)ccc2c1,DB00461,DrugBank Augmented,0.6111111111111112,train
DB00470,Dronabinol,DBMET01220,"8,11-Dihydroxy-delta-9-THC",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CC(O)C(CO)=CC21,DB00470,DrugBank Augmented,0.6440677966101694,train
DB00470,Dronabinol,DBMET01221,11-Nor-9-carboxy-delta-9-THC,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C(=O)O)=CC21,DB00470,DrugBank Augmented,0.75,train
DB00470,Dronabinol,DBMET03560,11-Hydroxy-delta-9-THC-glucuronide,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(COC3OC(C(=O)O)C(O)C(O)C3O)=CC21,DB00470,DrugBank Augmented,0.5833333333333334,train
DB00472,Fluoxetine,DBMET01363,Norfluoxetine alcohol,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,OCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,DB00472,DrugBank Augmented,0.7,train
DB00472,Fluoxetine,DBMET00198,4-Trifluoromethylphenol,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,Oc1ccc(C(F)(F)F)cc1,DB00472,DrugBank Augmented,0.275,train
DB00472,Fluoxetine,DBMET00964,Norfluoxetine glucuronide,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,O=C(O)C1OC(ONCCC(Oc2ccc(C(F)(F)F)cc2)c2ccccc2)C(O)C(O)C1O,DB00472,DrugBank Augmented,0.5535714285714286,train
DB00476,Duloxetine,DBMET00731,4-hydroxy duloxetine glucuronide,CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c2ccccc12)c1cccs1,DB00476,DrugBank Augmented,0.5409836065573771,train
DB00476,Duloxetine,DBMET02506,Catechol duloxetine,CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(O)c(O)ccc12)c1cccs1,DB00476,DrugBank Augmented,0.7083333333333334,train
DB00482,Celecoxib,DBMET00810,Carboxycelecoxib,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(C(=O)O)cc2)cc1,DB00482,DrugBank Augmented,0.7608695652173914,train
DB00497,Oxycodone,DBMET02514,alpha-oxymorphol,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3(O)C1C5,DB00497,DrugBank Augmented,0.5,train
DB00497,Oxycodone,DBMET00424,noroxymorphone,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3)C1O5,DB00497,DrugBank Augmented,0.484375,train
DB00497,Oxycodone,DBMET00425,alpha-noroxycodol,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4(O)C(C2)NCCC314,DB00497,DrugBank Augmented,0.4202898550724637,train
DB00502,Haloperidol,DBMET01211,Haloperidol reduced pyridinium ion derivative,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OC(CCC[n+]1ccc(-c2ccc(Cl)cc2)cc1)c1ccc(F)cc1,DB00502,DrugBank Augmented,0.2622950819672131,train
DB00502,Haloperidol,DBMET01212,Haloperidol pyridinium ion derivative,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)c1ccc(F)cc1,DB00502,DrugBank Augmented,0.4363636363636363,train
DB00531,Cyclophosphamide,DBMET01076,4-Ketocyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,O=C1CCOP(=O)(N(CCCl)CCCl)N1,DB00531,DrugBank Augmented,0.5405405405405406,train
DB00533,Rofecoxib,DBMET01292,cis-Dihydrorofecoxib,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,CS(=O)(=O)c1ccc(C2COC(=O)C2c2ccccc2)cc1,DB00533,DrugBank Augmented,0.4565217391304347,train
DB00533,Rofecoxib,DBMET00171,"Rofecoxib-threo-3,4-dihydrohydroxy acid",CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,CS(=O)(=O)c1ccc(C(CO)C(C(=O)O)c2ccccc2)cc1,DB00533,DrugBank Augmented,0.32,train
DB00533,Rofecoxib,DBMET01294,5-Hydroxyrofecoxib O-glucuronide,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2OC2OC(C(=O)O)C(O)C(O)C2O)cc1,DB00533,DrugBank Augmented,0.4137931034482758,train
DB00549,Zafirlukast,DBMET01251,Zafirlukast metabolite M2,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(C)=O)cc12,DB00549,DrugBank Augmented,0.7837837837837838,train
DB00549,Zafirlukast,DBMET01254,Zafirlukast metabolite M8,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1c[nH]c2ccc(NC(=O)OC3CCCC3)cc12,DB00549,DrugBank Augmented,0.7625,train
DB00559,Bosentan,DBMET01237,Bosentan metabolite Ro 64-1056,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,CC(C)(CO)c1ccc(S(=O)(=O)Nc2nc(-c3ncccn3)nc(OCCO)c2Oc2ccccc2O)cc1,DB00559,DrugBank Augmented,0.7878787878787878,train
DB00564,Carbamazepine,DBMET01101,"2,3-Dihydroxycarbamazepine",NC(=O)N1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C=Cc2cc(O)c(O)cc21,DB00564,DrugBank Augmented,0.7419354838709677,train
DB00564,Carbamazepine,DBMET00681,2-hydroxycarbamazepine,NC(=O)N1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C=Cc2cc(O)ccc21,DB00564,DrugBank Augmented,0.7419354838709677,train
DB00564,Carbamazepine,DBMET00806,"10,11-Dihydroxycarbamazepine",NC(=O)N1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,DB00564,DrugBank Augmented,0.5666666666666667,train
DB00574,Fenfluramine,DBMET03178,1-(3-trifluoromethyl-phenyl)-propan-2-one,CCNC(C)Cc1cccc(C(F)(F)F)c1,CC(=O)Cc1cccc(C(F)(F)F)c1,DB00574,DrugBank Augmented,0.4634146341463415,train
DB00574,Fenfluramine,DBMET03179,N-hydroxynorfenfluramine,CCNC(C)Cc1cccc(C(F)(F)F)c1,CC(Cc1cccc(C(F)(F)F)c1)NO,DB00574,DrugBank Augmented,0.7027027027027027,train
DB00580,Valdecoxib,DBMET01340,Valdecoxib metabolite M7,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)O)cc1,DB00580,DrugBank Augmented,0.5909090909090909,train
DB00580,Valdecoxib,DBMET01342,Valdecoxib metabolite M5,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,O=S(=O)(NO)c1ccc(-c2c(-c3ccccc3)noc2CO)cc1,DB00580,DrugBank Augmented,0.48,train
DB00580,Valdecoxib,DBMET01346,Valdecoxib metabolite M4,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C(=O)O)cc1,DB00580,DrugBank Augmented,0.6744186046511628,train
DB00580,Valdecoxib,DBMET01347,Valdecoxib metabolite M3,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,NS(=O)(=O)c1ccc(-c2c(-c3cccc(O)c3)noc2CO)cc1,DB00580,DrugBank Augmented,0.5,train
DB00582,Voriconazole,DBMET01184,4-Hydroxyvoriconazole 4-O-glucuronide,CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,O=C(O)C1OC(OCC(c2ncncc2F)C(O)(Cn2cncn2)c2ccc(F)cc2F)C(O)C(O)C1O,DB00582,DrugBank Augmented,0.581081081081081,train
DB00582,Voriconazole,DBMET01185,"UK-51,060",CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,O=C(Cn1cncn1)c1ccc(F)cc1F,DB00582,DrugBank Augmented,0.4,train
DB00586,Diclofenac,DBMET02608,"3',4'-hydroxy diclofenac",O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)Cc1ccccc1Nc1c(Cl)cc(O)c(O)c1Cl,DB00586,DrugBank Augmented,0.625,train
DB00586,Diclofenac,DBMET02611,4'-hydroxy-3'-glutathione conjugated diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSc1c(O)cc(Cl)c(Nc2ccccc2CC(=O)O)c1Cl)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.373134328358209,train
DB00586,Diclofenac,DBMET02612,4'-hydroxy-2'-glutathione conjugated monoclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSc1cc(O)cc(Cl)c1Nc1ccccc1CC(=O)O)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.3846153846153846,train
DB00586,Diclofenac,DBMET02614,"5,N-dihydroxy diclofenac",O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)Cc1cc(O)ccc1N(O)c1c(Cl)cccc1Cl,DB00586,DrugBank Augmented,0.4,train
DB00586,Diclofenac,DBMET01258,"4',5-Dihydroxydiclofenac",O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)Cc1cc(O)ccc1Nc1c(Cl)cc(O)cc1Cl,DB00586,DrugBank Augmented,0.5384615384615384,train
DB00586,Diclofenac,DBMET02615,5-hydroxy-4-glutathione conjugated diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSc1cc(Nc2c(Cl)cccc2Cl)c(CC(=O)O)cc1O)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.3846153846153846,train
DB00586,Diclofenac,DBMET02616,5-hydroxy-6-glutathione conjugated diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSc1c(O)ccc(Nc2c(Cl)cccc2Cl)c1CC(=O)O)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.3676470588235294,train
DB00586,Diclofenac,DBMET02618,"2-(2,6-dichlorophenylamino)-benzyl-S-thioether glutathione",O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSCC1C=CC=CC1=Nc1c(Cl)cccc1Cl)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.2236842105263158,train
DB00586,Diclofenac,DBMET02620,2'-hydroxy-3'-glutathione conjugated diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSC1C=CC(Cl)=C(Nc2ccccc2CC(=O)O)C1(O)Cl)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.2972972972972973,train
DB00586,Diclofenac,DBMET02621,,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSC1C(Nc2ccccc2CC(=O)O)=C(Cl)C=CC1O)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.3098591549295774,train
DB00586,Diclofenac,DBMET02623,2'-(glutathion-S-yl)-deschloro-diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NC(CCC(=O)NC(CSc1cccc(Cl)c1Nc1ccccc1CC(=O)O)C(=O)NCC(=O)O)C(=O)O,DB00586,DrugBank Augmented,0.4666666666666667,train
DB00598,Labetalol,DBMET02672,Labetalol Phenolic Glucuronide Metabolite (V),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,CC(CCc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)NCC(O)c1ccc(O)c(C(N)=O)c1,DB00598,DrugBank Augmented,0.6268656716417911,train
DB00598,Labetalol,DBMET02674,Labetalol C1' Glucuronidated Metabolite (VII),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,CC(CCc1ccccc1)NCC(OC1OC(C(=O)O)C(O)C(O)C1O)c1cc(O)c(O)c(C(N)=O)c1,DB00598,DrugBank Augmented,0.5,train
DB00598,Labetalol,DBMET02675,Labetalol C3 Glucuronidated Metabolite (VIII),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,CC(CCc1ccccc1)NCC(O)c1cc(OC2OC(C(=O)O)C(O)C(O)C2O)c(O)c(C(N)=O)c1,DB00598,DrugBank Augmented,0.5571428571428572,train
DB00598,Labetalol,DBMET02676,Labetalol Theoretical Metabolite (IX),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,CC(CCc1ccccc1)n1ccc2cc(O)c(O)c(C(N)=O)c21,DB00598,DrugBank Augmented,0.40625,train
DB00603,Medroxyprogesterone acetate,DBMET02813,"1,2-dehydromedroxyprogesterone acetate (M-5)",CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C,CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3CCC21C,DB00603,DrugBank Augmented,0.6724137931034483,train
DB00608,Chloroquine,DBMET03063,N-bidesethylchloroquine,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,CC(CCCN)Nc1ccnc2cc(Cl)ccc12,DB00608,DrugBank Augmented,0.7291666666666666,train
DB01420,Testosterone propionate,DBMET00574,5a-Dihydrotestosterone sulfate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,DB01420,DrugBank Augmented,0.3582089552238806,train
DB01420,Testosterone propionate,DBMET02832,5-alpha androstanediol,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented,0.2539682539682539,train
DB01420,Testosterone propionate,DBMET02831,5-alpha androsterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented,0.328125,train
DB15566,Prednisolone acetate,DBMET02862,"17α,20ξ,21-trihydroxy-5ξ-pregn-1-en-3,11-dione(M-XVIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented,0.2682926829268293,train
DB15566,Prednisolone acetate,DBMET02852,"6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-X)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented,0.4246575342465753,train
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented,0.4507042253521127,train
DB00661,Verapamil,DBMET01234,Verapamil metabolite D-620,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,DB00661,DrugBank Augmented,0.6470588235294118,train
DB00661,Verapamil,DBMET01235,Verapamil metabolite PR-25,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,CNCCCC(C#N)(c1ccc(O)c(OC)c1)C(C)C,DB00661,DrugBank Augmented,0.5,train
DB00661,Verapamil,DBMET01236,Verapamil metabolite D-715 (PR-22),COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCNCCc2ccc(OC)c(OC)c2)C(C)C)cc1O,DB00661,DrugBank Augmented,0.6065573770491803,train
DB00669,Sumatriptan,DBMET02584,Sumatriptan Metabolite Ester Glucuronide of GR49336,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,CNS(=O)(=O)Cc1ccc2[nH]cc(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)c2c1,DB00669,DrugBank Augmented,0.4923076923076923,train
DB00672,Chlorpropamide,DBMET00977,4-Chlorobenzenesulfonamide,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,NS(=O)(=O)c1ccc(Cl)cc1,DB00672,DrugBank Augmented,0.3513513513513513,train
DB00675,Tamoxifen,DBMET02699,N-desmethyltamoxifen Sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(OCCN(C)S(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.7272727272727273,train
DB00675,Tamoxifen,DBMET01044,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.6222222222222222,train
DB00675,Tamoxifen,DBMET02705,α-hydroxytamoxifen Glucuronide,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CC(OC1OC(C(=O)O)C(O)C(O)C1O)C(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.4590163934426229,train
DB00675,Tamoxifen,DBMET02704,α-tamoxifen Sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CC(OS(=O)(=O)O)C(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.5490196078431373,train
DB00675,Tamoxifen,DBMET00737,4-hydroxytamoxifen sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCN(C)C)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.7954545454545454,train
DB00675,Tamoxifen,DBMET02702,Tamoxifen Glucuronides,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.4666666666666667,train
DB00675,Tamoxifen,DBMET02714,"N,N-didesmethyltamoxifen",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(OCCN)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.7,train
DB00678,Losartan,DBMET00303,Losartan carboxylic acid,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CCCCc1nc(Cl)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,DB00678,DrugBank Augmented,0.582089552238806,train
DB00682,Warfarin,DBMET02563,(E)-dehydrowarfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,CC(=O)C=C(c1ccccc1)c1c(O)c2ccccc2oc1=O,DB00682,DrugBank Augmented,0.4705882352941176,train
DB00706,Tamsulosin,DBMET02493,Tamsulosin M-2-Glu Metabolite,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,CCOc1cc(OC2OC(C(=O)O)C(O)C(O)C2O)ccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,DB00706,DrugBank Augmented,0.6301369863013698,train
DB00706,Tamsulosin,DBMET02494,Tamsulosin M-4-Glu Metabolite,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,CCOc1ccccc1OCCNC(C)Cc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(S(N)(=O)=O)c1,DB00706,DrugBank Augmented,0.6521739130434783,train
DB00706,Tamsulosin,DBMET02495,Tamsulosin M-1-Glu Metabolite,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,COc1ccc(CC(C)NCCOc2ccccc2OC2OC(C(=O)O)C(O)C(O)C2O)cc1S(N)(=O)=O,DB00706,DrugBank Augmented,0.6521739130434783,train
DB00706,Tamsulosin,DBMET02496,Tamsulosin M-1-Sul Metabolite,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,COc1ccc(CC(C)NCCOc2ccccc2OS(=O)(=O)O)cc1S(N)(=O)=O,DB00706,DrugBank Augmented,0.8035714285714286,train
DB00706,Tamsulosin,DBMET02497,Tamsulosin M-3-Glu Metabolite,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,CCOc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,DB00706,DrugBank Augmented,0.6301369863013698,train
DB00706,Tamsulosin,DBMET02498,Tamsulosin M-3-Sul Metabolite,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,CCOc1ccc(OS(=O)(=O)O)cc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,DB00706,DrugBank Augmented,0.7666666666666667,train
DB00717,Norethisterone,DBMET02892,"3α,5α-tetrahydronorethisterone",C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,C#CC1(O)CCC2C3CCC4CC(O)CCC4C3CCC21C,DB00717,DrugBank Augmented,0.4642857142857143,train
DB00744,Zileuton,DBMET01255,Dehydroxyzileuton sulfoxide,CC(c1cc2ccccc2s1)N(O)C(N)=O,CC(NC(N)=O)c1cc2ccccc2[s+]1[O-],DB00744,DrugBank Augmented,0.3018867924528302,train
DB00755,Tretinoin,DBMET03637,"rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,DB00755,DrugBank Augmented,0.3013698630136986,train
DB00758,Clopidogrel,DBMET01163,Active Metabolite of Clopidogrel,COC(=O)C(c1ccccc1Cl)N1CCc2sccc2C1,COC(=O)C(c1ccccc1Cl)N1CCC(S)=C(CC(=O)O)C1,DB00758,DrugBank Augmented,0.5862068965517241,train
DB00763,Methimazole,DBMET02769,Methimazole Sulfinic Acid Metabolite (Ring),Cn1cc[nH]c1=S,Cn1ccnc1S(=O)O,DB00763,DrugBank Augmented,0.2058823529411764,train
DB00770,Alprostadil,DBMET03613,15-keto-PGE0,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,CCCCCC(=O)CCC1C(O)CC(=O)C1CCCCCCC(=O)O,DB00770,DrugBank Augmented,0.5636363636363636,train
DB00773,Etoposide,DBMET01265,Etoposide ortho-quinone,COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O,COC1=CC(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(=O)C1=O,DB00773,DrugBank Augmented,0.7088607594936709,train
DB00776,Oxcarbazepine,DBMET02803,"trans-10,11-dihydro-10,11-dihydroxycarbamazepine",NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,DB00776,DrugBank Augmented,0.4594594594594595,train
DB00776,Oxcarbazepine,DBMET02805,(R)-MHD glucuronide metabolite,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2CC(OC2OC(C(=O)O)C(O)C(O)C2O)c2ccccc21,DB00776,DrugBank Augmented,0.3684210526315789,train
DB00788,Naproxen,DBMET01259,O-Desmethylnaproxen sulfate,COc1ccc2cc(C(C)C(=O)O)ccc2c1,CC(C(=O)O)c1ccc2cc(OS(=O)(=O)O)ccc2c1,DB00788,DrugBank Augmented,0.6756756756756757,train
DB00788,Naproxen,DBMET01260,O-Desmethylnaproxen acyl glucuronide,COc1ccc2cc(C(C)C(=O)O)ccc2c1,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)c1ccc2cc(O)ccc2c1,DB00788,DrugBank Augmented,0.3962264150943396,train
DB00788,Naproxen,DBMET01261,O-Desmethylnaproxen O-glucuronide,COc1ccc2cc(C(C)C(=O)O)ccc2c1,CC(C(=O)O)c1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00788,DrugBank Augmented,0.5434782608695652,train
DB00795,Sulfasalazine,DBMET03576,5'-hydroxysulfapyridine-O-glucuronide,O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,Nc1ccc(S(=O)(=O)Nc2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cn2)cc1,DB00795,DrugBank Augmented,0.3150684931506849,train
DB00806,Pentoxifylline,DBMET03235,"M7, 7-demethylated M1 Pentoxifylline",CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,CC(O)CCCCn1c(=O)c2[nH]cnc2n(C)c1=O,DB00806,DrugBank Augmented,0.4074074074074074,train
DB00808,Indapamide,DBMET01332,Indapamide metabolite M4,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CC1C(=O)c2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,DB00808,DrugBank Augmented,0.6666666666666666,train
DB00808,Indapamide,DBMET01335,Indapamide metabolite M3,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,Cc1cc2cc(O)ccc2n1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,DB00808,DrugBank Augmented,0.4615384615384615,train
DB00808,Indapamide,DBMET01337,Indapamide metabolite M6,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CC1CC2=C(C=CC(O)C2O)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,DB00808,DrugBank Augmented,0.6129032258064516,train
DB00813,Fentanyl,DBMET02570,Hydroxynorfentanyl,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,O=C(CCO)N(c1ccccc1)C1CCNCC1,DB00813,DrugBank Augmented,0.4313725490196078,train
DB00814,Meloxicam,DBMET00754,5'-carboxy meloxicam,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,CN1C(C(=O)Nc2ncc(C(=O)O)s2)=C(O)c2ccccc2S1(=O)=O,DB00814,DrugBank Augmented,0.7647058823529411,train
DB00857,Terbinafine,DBMET01178,Carboxyterbinafine,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CN(CC=CC#CC(C)(C)C(=O)O)Cc1cccc2ccccc12,DB00857,DrugBank Augmented,0.7446808510638298,train
DB00857,Terbinafine,DBMET01179,N-Desmethylhydroxyterbinafine,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C#CC=CCNCc1cccc2ccccc12)CO,DB00857,DrugBank Augmented,0.4629629629629629,train
DB00857,Terbinafine,DBMET01180,1-Naphthoic acid,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,O=C(O)c1cccc2ccccc12,DB00857,DrugBank Augmented,0.2291666666666666,train
DB00857,Terbinafine,DBMET01181,1-Naphthalenemethanol,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,OCc1cccc2ccccc12,DB00857,DrugBank Augmented,0.3333333333333333,train
DB00857,Terbinafine,DBMET01205,N-Desmethylterbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C)C#CC=CCNCc1cc(O)c(O)c2ccccc12,DB00857,DrugBank Augmented,0.4035087719298245,train
DB00857,Terbinafine,DBMET01206,N-Desmethylterbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C)C#CC=CCNCc1cccc2c(O)c(O)ccc12,DB00857,DrugBank Augmented,0.4210526315789473,train
DB14596,Loteprednol etabonate,DBMET02134,Δ1-cortienic acid (PJ-90),CCOC(=O)OC1(C(=O)OCCl)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)O,DB14596,DrugBank Augmented,0.5671641791044776,train
DB00881,Quinapril,DBMET02776,Quinapril Metabolite PD113413,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,CC1C(=O)N2Cc3ccccc3CC2C(=O)N1C(CCc1ccccc1)C(=O)O,DB00881,DrugBank Augmented,0.4057971014492754,train
DB00949,Felbamate,DBMET01094,3-Carbamoyl-2-phenylpropionaldehyde,NC(=O)OCC(COC(N)=O)c1ccccc1,NC(=O)OCC(C=O)c1ccccc1,DB00949,DrugBank Augmented,0.625,train
DB00953,Rizatriptan,DBMET03670,6-Hydroxy rizatriptan sulfate,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,CN(C)CCc1c[nH]c2cc(OS(=O)(=O)O)c(Cn3cncn3)cc12,DB00953,DrugBank Augmented,0.5833333333333334,train
DB15465,Benzhydrocodone,DBMET02728,6-β-hydrocodol glucuronide conjugate,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(OC4OC(C(=O)O)C(O)C(O)C4O)CCC4C(C2)N(C)CCC341,DB15465,DrugBank Augmented,0.4939759036144578,train
DB15465,Benzhydrocodone,DBMET02724,6-β-hydromorphol glucuronide conjugate 1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented,0.4457831325301205,train
DB15465,Benzhydrocodone,DBMET02725,6-β-hydromorphol glucuronide conjugate 2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)CCC3C1C5,DB15465,DrugBank Augmented,0.4022988505747126,train
DB00957,Norgestimate,DB09389,Norgestrel,C#CC1(OC(C)=O)CCC2C3CCC4=CC(=NO)CCC4C3CCC21CC,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC,DB00957,DrugBank Augmented,0.5373134328358209,train
DB00959,Methylprednisolone,DBMET02921,Methylprednisolone M14 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC12C=CC(=O)C=C1C(CO)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB00959,DrugBank Augmented,0.5606060606060606,train
DB00959,Methylprednisolone,DBMET02922,Methylprednisolone M15 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC12C=CC(=O)C=C1C(CO)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB00959,DrugBank Augmented,0.5606060606060606,train
DB00959,Methylprednisolone,DBMET02925,Methylprednisolone M10 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1(O)CC2C(C(O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented,0.4925373134328358,train
DB00959,Methylprednisolone,DBMET02927,Methylprednisolone M5 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1=CC2C(C(O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented,0.3972602739726027,train
DB00959,Methylprednisolone,DBMET02932,Methylprednisolone M8 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1CC2C(C(=O)CC3(C)C2CC(O)C3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented,0.5223880597014925,train
DB00959,Methylprednisolone,DBMET02933,Methylprednisolone M11 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1CC2C(C(=O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented,0.5147058823529411,train
DB00968,Methyldopa,DBMET00704,3-O-methyl-alpha-methyldopamine,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,COc1cc(CC(C)N)ccc1O,DB00968,DrugBank Augmented,0.2888888888888888,train
DB00968,Methyldopa,DBMET00784,3-O-methyl-alpha-methyldopa sulfate,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,COc1ccc(CC(C)(N)C(=O)O)cc1OS(=O)(=O)O,DB00968,DrugBank Augmented,0.5111111111111111,train
DB00968,Methyldopa,DBMET03314,Alpha-methylnorepinephrine,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,CC(N)C(O)c1ccc(O)c(O)c1,DB00968,DrugBank Augmented,0.2926829268292683,train
DB00190,Carbidopa,DBMET03316,"3,4-Dihydroxyphenylacetone glucuronide",CC(Cc1ccc(O)c(O)c1)(NN)C(=O)O,CC(=O)Cc1ccc(O)c(OC2OC(C(=O)O)C(O)C(O)C2O)c1,DB00190,DrugBank Augmented,0.2542372881355932,train
DB00973,Ezetimibe,DBMET02117,SCH 57871-glucuronide,O=C1C(CCC(O)c2ccc(F)cc2)C(c2ccc(O)cc2)N1c1ccc(F)cc1,O=C(CCC1C(=O)N(c2ccc(F)cc2)C1c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccc(F)cc1,DB00973,DrugBank Augmented,0.4027777777777778,train
DB00997,Doxorubicin,DBMET01079,Doxirubicinol hydroxyaglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(O)CO)CC3O,DB00997,DrugBank Augmented,0.5,train
DB00997,Doxorubicin,DBMET00847,Doxorubicinol deoxaglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented,0.4166666666666667,train
DB00997,Doxorubicin,DBMET01078,Doxorubicine hydroxyaglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3O,DB00997,DrugBank Augmented,0.6438356164383562,train
DB01006,Letrozole,DBMET00376,"4,4'-methanol-bisbenzonitrile",N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,N#Cc1ccc(C(O)c2ccc(C#N)cc2)cc1,DB01006,DrugBank Augmented,0.4375,train
DB01015,Sulfamethoxazole,DBMET01048,N4-Acetyl-5-OH-sulfamethoxazole,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(CO)on2)cc1,DB01015,DrugBank Augmented,0.4489795918367347,train
DB01015,Sulfamethoxazole,DBMET01049,Nitroso-sulfamethoxazole,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,Cc1cc(NS(=O)(=O)c2ccc(N=O)cc2)no1,DB01015,DrugBank Augmented,0.6923076923076923,train
DB01018,Guanfacine,DBMET02969,Guanfacine 3-glucuronide,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,N=C(N)NC(=O)Cc1c(Cl)ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c1Cl,DB01018,DrugBank Augmented,0.4528301886792453,train
DB01018,Guanfacine,DBMET02970,Guanfacine 3-sulfate,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,N=C(N)NC(=O)Cc1c(Cl)ccc(OS(=O)(=O)O)c1Cl,DB01018,DrugBank Augmented,0.5581395348837209,train
DB01022,Phylloquinone,DBMET03368,Phylloquinone carboxylic acid metabolite,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C(=O)O,DB01022,DrugBank Augmented,0.7959183673469388,train
DB01026,Ketoconazole,DBMET02654,M6 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)c(O)c2O)CC1,DB01026,DrugBank Augmented,0.7468354430379747,train
DB01026,Ketoconazole,DBMET02656,M12 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)C(=O)C1,DB01026,DrugBank Augmented,0.8289473684210527,train
DB01026,Ketoconazole,DBMET02657,Ketoconazole iminium ion,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CC=[N+](c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.7407407407407407,train
DB01026,Ketoconazole,DBMET02658,M10 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)NCCNc1ccc(OCC2COC(Cn3ccnc3)(c3ccc(Cl)cc3Cl)O2)cc1,DB01026,DrugBank Augmented,0.7088607594936709,train
DB01026,Ketoconazole,DBMET02661,Ketoconazole ketone intermediate,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NCC4=O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.7088607594936709,train
DB01026,Ketoconazole,DBMET02665,Ketoconazole dihydroxyl intermediate,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NC(O)C4O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.7567567567567568,train
DB01029,Irbesartan,DBMET01055,Irbesartan derivative M1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented,0.6388888888888888,train
DB01029,Irbesartan,DBMET01057,Irbesartan derivative M6,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(=O)CCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented,0.7777777777777778,train
DB01039,Fenofibrate,DBMET02799,Reduced Fenofibric Acid Glucuronide,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,CC(C)(Oc1ccc(C(O)c2ccc(Cl)cc2)cc1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,DB01039,DrugBank Augmented,0.4,train
DB01041,Thalidomide,DBMET00034,5-Hydroxythalidomide,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C1CCC(N2C(=O)c3ccc(O)cc3C2=O)C(=O)N1,DB01041,DrugBank Augmented,0.7105263157894737,train
DB01041,Thalidomide,DBMET01117,2-phthalimidoglutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=O,DB01041,DrugBank Augmented,0.2553191489361702,train
DB01041,Thalidomide,DBMET01114,"5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C1CCC(N2C(=O)c3cc(O)c(O)cc3C2=O)C(=O)N1,DB01041,DrugBank Augmented,0.6944444444444444,train
DB01041,Thalidomide,DBMET03444,"cis,trans-5,5’-dihydroxythalidomide",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C1NC(=O)C(N2C(=O)c3ccc(O)cc3C2=O)CC1O,DB01041,DrugBank Augmented,0.4130434782608695,train
DB01041,Thalidomide,DBMET03446,alpha-aminoglutarimide,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC1CCC(=O)NC1=O,DB01041,DrugBank Augmented,0.4,train
DB01050,Ibuprofen,DBMET00808,Carboxy-ibuprofen,CC(C)Cc1ccc(C(C)C(=O)O)cc1,CC(Cc1ccc(C(C)C(=O)O)cc1)C(=O)O,DB01050,DrugBank Augmented,0.7857142857142857,train
DB01060,Amoxicillin,DBMET03000,Amoxicillin M4 Metabolite,CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O,CC1(C=O)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O,DB01060,DrugBank Augmented,0.7818181818181819,train
DB01065,Melatonin,DBMET00763,6-Hydroxymelatonin sulfate,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,COc1cc2c(CCNC(C)=O)c[nH]c2cc1OS(=O)(=O)O,DB01065,DrugBank Augmented,0.5849056603773585,train
DB01065,Melatonin,DBMET00926,N-Acetyl-5-hydroxytryptamine sulfate,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,CC(=O)NCCc1c[nH]c2ccc(OS(=O)(=O)O)cc12,DB01065,DrugBank Augmented,0.7446808510638298,train
DB01065,Melatonin,DBMET00925,N-Acetyl-5-hydroxytryptamine glucuronide,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,CC(=O)NCCc1c[nH]c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc12,DB01065,DrugBank Augmented,0.603448275862069,train
DB01065,Melatonin,DBMET00762,6-Hydroxymelatonin glucuronide,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,COc1cc2c(CCNC(C)=O)c[nH]c2cc1OC1OC(C(=O)O)C(O)C(O)C1O,DB01065,DrugBank Augmented,0.492063492063492,train
DB01065,Melatonin,DBMET01360,Pinoline,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,COc1ccc2[nH]c3c(c2c1)CCNC3,DB01065,DrugBank Augmented,0.3584905660377358,train
DB01068,Clonazepam,DBMET03609,3-hydroxy-7-amino-clonazepam,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,Nc1ccc2c(c1)C(c1ccccc1Cl)=NC(O)C(=O)N2,DB01068,DrugBank Augmented,0.4,train
DB01068,Clonazepam,DBMET03611,glucuronyl-3-hydroxy-clonazepam,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,O=C1Nc2ccc([N+](=O)[O-])cc2C(c2ccccc2Cl)=NC1OC1OC(C(=O)O)C(O)C(O)C1O,DB01068,DrugBank Augmented,0.4722222222222222,train
DB01068,Clonazepam,DBMET02278,7-acetamido-clonazepam,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,CC(=O)Nc1ccc2c(c1)C(c1ccccc1Cl)=NCC(=O)N2,DB01068,DrugBank Augmented,0.6,train
DB01076,Atorvastatin,DBMET01266,para-hydroxyatorvastatin lactone,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,CC(C)c1c(C(=O)Nc2ccc(O)cc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,DB01076,DrugBank Augmented,0.9298245614035088,train
DB01076,Atorvastatin,DBMET01267,ortho-hydroxyatorvastatin lactone,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,DB01076,DrugBank Augmented,0.8333333333333334,train
DB01076,Atorvastatin,DBMET02422,para-hydroxyatorvastatin glucuronide,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,CC(C)c1c(C(=O)Nc2ccc(O)cc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)OC1OC(C(=O)O)C(O)C(O)C1O,DB01076,DrugBank Augmented,0.6282051282051282,train
DB01076,Atorvastatin,DBMET02423,ortho-hydroxyatorvastatin glucuronide,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)OC1OC(C(=O)O)C(O)C(O)C1O,DB01076,DrugBank Augmented,0.5679012345679012,train
DB01088,Iloprost,DBMET03768,Tetranor-iloprost,CC#CCC(C)C(O)C=CC1C(O)CC2CC(=CCCCC(=O)O)CC21,CC#CCC(C)C(O)C=CC1C(O)CC2CC(C(=O)O)CC21,DB01088,DrugBank Augmented,0.6229508196721312,train
DB01101,Capecitabine,DBMET00656,5’-Deoxy-5-fluorouridine (5'DFUR),CCCCCOC(=O)Nc1nc(=O)n(C2OC(C)C(O)C2O)cc1F,CC1OC(n2cc(F)c(=O)[nH]c2=O)C(O)C1O,DB01101,DrugBank Augmented,0.4426229508196721,train
DB00322,Floxuridine,DBMET03586,5-fluorouridine monophosphate (5-FUMP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented,0.5,train
DB00322,Floxuridine,DBMET03591,5-fluouridine (5-FUR),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(CO)C(O)C2O)cc1F,DB00322,DrugBank Augmented,0.6444444444444445,train
DB01120,Gliclazide,DBMET01328,Carboxygliclazide,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,O=C(NN1CC2CCCC2C1)NS(=O)(=O)c1ccc(C(=O)O)cc1,DB01120,DrugBank Augmented,0.7441860465116279,train
DB01132,Pioglitazone,DBMET01303,Pioglitazone metabolite M-XI,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,CC(O)c1ccc(C(O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1,DB01132,DrugBank Augmented,0.5161290322580645,train
DB01132,Pioglitazone,DBMET01304,Pioglitazone metabolite M-VI,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,O=C1NC(=O)C(Cc2ccc(OCCc3ccc(C(=O)O)cn3)cc2)S1,DB01132,DrugBank Augmented,0.7307692307692307,train
DB01132,Pioglitazone,DBMET01307,Pioglitazone metabolite M-III,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,CC(=O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,DB01132,DrugBank Augmented,0.7647058823529411,train
DB01142,Doxepin,DBMET00834,Didesmethyl doxepin,CN(C)CCC=C1c2ccccc2COc2ccccc21,NCCC=C1c2ccccc2COc2ccccc21,DB01142,DrugBank Augmented,0.6923076923076923,train
DB01142,Doxepin,DBMET00845,Doxepin N-oxide glucuronide,CN(C)CCC=C1c2ccccc2COc2ccccc21,C[N+](C)(CCC=C1c2ccccc2COc2ccccc21)OC1OC(C(=O)O)C(O)C(O)C1O,DB01142,DrugBank Augmented,0.4590163934426229,train
DB01142,Doxepin,DBMET00881,Hydroxydoxepin glucuronide,CN(C)CCC=C1c2ccccc2COc2ccccc21,CN(C)CCC=C1c2ccccc2COc2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc21,DB01142,DrugBank Augmented,0.5245901639344263,train
DB01142,Doxepin,DBMET00872,Hydroxydesmethyl doxepin,CN(C)CCC=C1c2ccccc2COc2ccccc21,CNCCC=C1c2ccccc2COc2ccc(O)cc21,DB01142,DrugBank Augmented,0.52,train
DB01156,Bupropion,DBMET03485,"S,R-erythro-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented,0.3333333333333333,train
DB01156,Bupropion,DBMET03486,"S,R-erythrohydrobupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented,0.3833333333333333,train
DB01156,Bupropion,DBMET03487,S-4'-hydroxybupropion glucuronide,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(=O)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(Cl)c1,DB01156,DrugBank Augmented,0.4385964912280701,train
DB01156,Bupropion,DBMET03490,R-4'-hydroxybupropion sulfate,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(=O)c1ccc(OS(=O)(=O)O)c(Cl)c1,DB01156,DrugBank Augmented,0.5652173913043478,train
DB01156,Bupropion,DBMET03469,"S,S-Hydroxybupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC1NC(C)(C)COC1(O)c1cccc(Cl)c1,DB01156,DrugBank Augmented,0.2363636363636363,train
DB01156,Bupropion,DBMET03478,"S,S-threohydrobupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(OC1OC(C(=O)O)C(C)C(C)C1C)c1cccc(Cl)c1,DB01156,DrugBank Augmented,0.3833333333333333,train
DB01161,Chloroprocaine,DBMET03557,N-acetyl-2-chloro-p-aminobenzoic acid,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,CC(=O)Nc1ccc(C(=O)O)c(Cl)c1,DB01161,DrugBank Augmented,0.2857142857142857,train
DB01162,Terazosin,DBMET02359,Diamine Metabolite Of The Piperazine Compound,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,COc1cc2nc(N)nc(N)c2cc1OC,DB01162,DrugBank Augmented,0.3928571428571428,train
DB01171,Moclobemide,DBMET02151,Moclobemide M6,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,O=C(NCC[N+]1([O-])CCOCC1O)c1ccc(Cl)cc1,DB01171,DrugBank Augmented,0.4716981132075472,train
DB01174,Phenobarbital,DBMET01217,Phenobarbital O-sulfate,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,CCC1(c2ccc(OS(=O)(=O)O)cc2)C(=O)NC(=O)NC1=O,DB01174,DrugBank Augmented,0.5526315789473685,train
DB01174,Phenobarbital,DBMET01218,Phenobarbital O-glucuronide,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,CCC1(c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc2)C(=O)NC(=O)NC1=O,DB01174,DrugBank Augmented,0.4489795918367347,train
DB01221,Ketamine,DBMET01308,4-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CC(O)CCC1=O,DB01221,DrugBank Augmented,0.375,train
DB01221,Ketamine,DBMET01309,5-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CCC(O)CC1=O,DB01221,DrugBank Augmented,0.375,train
DB01221,Ketamine,DBMET01310,6-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CCCC(O)C1=O,DB01221,DrugBank Augmented,0.3829787234042553,train
DB01222,Budesonide,DBMET02913,16alpha-butyrloxyprednisolone,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,CCCC(=O)OC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1(O)C(=O)CO,DB01222,DrugBank Augmented,0.5789473684210527,train
DB01227,Levacetylmethadol,DBMET00843,Dinor-levomethadyl acetate,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,CCC(OC(C)=O)C(CC(C)N)(c1ccccc1)c1ccccc1,DB01227,DrugBank Augmented,0.7380952380952381,train
DB01235,Levodopa,DBMET02447,"3,4-dihydroxyphenylethanol (DOPET)",NC(Cc1ccc(O)c(O)c1)C(=O)O,OCCc1ccc(O)c(O)c1,DB01235,DrugBank Augmented,0.4242424242424242,train
DB01235,Levodopa,DBMET02441,3-methoxy-4-hydroxyacetaldehyde,NC(Cc1ccc(O)c(O)c1)C(=O)O,COc1cc(CC=O)ccc1O,DB01235,DrugBank Augmented,0.2857142857142857,train
DB01235,Levodopa,DBMET02446,"3,4-dihydroxyphenylacetic acid (DOPAC)",NC(Cc1ccc(O)c(O)c1)C(=O)O,O=C(O)Cc1ccc(O)c(O)c1,DB01235,DrugBank Augmented,0.53125,train
DB01242,Clomipramine,DBMET00835,didesmethylclomipramine,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,NCCCN1c2ccccc2CCc2ccc(Cl)cc21,DB01242,DrugBank Augmented,0.7142857142857143,train
DB01242,Clomipramine,DBMET01069,2-hydroxydesmethyl clomipramine,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CNCCCN1c2ccccc2CCc2cc(O)c(Cl)cc21,DB01242,DrugBank Augmented,0.4814814814814814,train
DB01242,Clomipramine,DBMET01071,2-hydroxyclomipramine glucuronide,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CN(C)CCCN1c2cc(Cl)c(O)cc2CCc2c(OC3OC(C(=O)O)C(O)C(O)C3O)cccc21,DB01242,DrugBank Augmented,0.3866666666666666,train
DB01242,Clomipramine,DBMET01072,8-hydroxyclomipramine glucuronide,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CN(C)CCCN1c2cc(Cl)ccc2CCc2c1ccc(O)c2OC1OC(C(=O)O)C(O)C(O)C1O,DB01242,DrugBank Augmented,0.4714285714285714,train
DB01242,Clomipramine,DBMET01073,8-hydroxydesmethyl clomipramine,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CNCCCN1c2ccc(O)cc2CCc2ccc(Cl)cc21,DB01242,DrugBank Augmented,0.5192307692307693,train
DB01261,Sitagliptin,DBMET02433,Sitagliptin M4 Metabolite,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F)OC1OC(C(=O)O)C(O)C(O)C1O,DB01261,DrugBank Augmented,0.5714285714285714,train
DB01275,Hydralazine,DBMET02814,Hydralazine pyruvate hydrazone tricyclic dehydration product,NNc1nncc2ccccc12,Cc1nnc2c3ccccc3cnn2c1=O,DB01275,DrugBank Augmented,0.2954545454545454,train
DB01275,Hydralazine,DBMET00864,Hydralazine pyruvate hydrazone,NNc1nncc2ccccc12,CC(=NNc1nncc2ccccc12)C(=O)O,DB01275,DrugBank Augmented,0.5,train
DB01275,Hydralazine,DBMET02815,Phthalazinone,NNc1nncc2ccccc12,O=c1[nH]ncc2ccccc12,DB01275,DrugBank Augmented,0.3333333333333333,train
DB01275,Hydralazine,DBMET02819,Acetylhydrazinophthalazinone,NNc1nncc2ccccc12,CC(=O)NNc1n[nH]c(=O)c2ccccc12,DB01275,DrugBank Augmented,0.2127659574468085,train
DB01275,Hydralazine,DBMET02821,3-methyl-s-triazolophthalazine,NNc1nncc2ccccc12,Cc1nnc2c3ccccc3cnn12,DB01275,DrugBank Augmented,0.325,train
DB01283,Lumiracoxib,DBMET01275,5-Carboxylumiracoxib (M11),Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(C(=O)O)ccc1Nc1c(F)cccc1Cl,DB01283,DrugBank Augmented,0.7333333333333333,train
DB01283,Lumiracoxib,DBMET01281,4'-Carboxylumiracoxib glucuronide (M22),Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,Cc1ccc(Nc2c(F)cc(O)cc2Cl)c(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)c1,DB01283,DrugBank Augmented,0.4626865671641791,train
DB01283,Lumiracoxib,DBMET01282,Lumiracoxib metabolite M25,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,Cc1ccc2c(c1)CC(=O)N2c1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented,0.2698412698412698,train
DB01283,Lumiracoxib,DBMET01284,Lumiracoxib metabolite M9,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(CO)ccc1Nc1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented,0.5094339622641509,train
DB01355,Hexobarbital,DBMET01214,3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,DB01355,DrugBank Augmented,0.6410256410256411,train
DB01355,Hexobarbital,DBMET01216,Hexobarbital dihydrodiol derivative,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,CN1C(=O)NC(=O)C(C)(C2(O)CCCCC2O)C1=O,DB01355,DrugBank Augmented,0.3469387755102041,train
DB01420,Testosterone propionate,DBMET00593,3-alpha-Androstanediol glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented,0.240506329113924,train
DB01589,Quazepam,DBMET00933,Norflurazepam,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1,DB01589,DrugBank Augmented,0.4821428571428571,train
DB01589,Quazepam,DBMET03600,3-hydroxy-2-oxoquazepam,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,O=C1C(O)N=C(c2ccccc2F)c2cc(Cl)ccc2N1CC(F)(F)F,DB01589,DrugBank Augmented,0.5862068965517241,train
DB01601,Lopinavir,DBMET03071,Lopinavir M1 metabolite,Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCC(=O)NC1=O,DB01601,DrugBank Augmented,0.7945205479452054,train
DB01620,Pheniramine,DBMET02636,N-didesmethylpheniramine,CN(C)CCC(c1ccccc1)c1ccccn1,NCCC(c1ccccc1)c1ccccn1,DB01620,DrugBank Augmented,0.6285714285714286,train
DB01628,Etoricoxib,DBMET01271,6-Hydroxymethyletoricoxib 1'-N'-oxide,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,CS(=O)(=O)c1ccc(-c2cc(Cl)cnc2-c2ccc(CO)[n+]([O-])c2)cc1,DB01628,DrugBank Augmented,0.64,train
DB01628,Etoricoxib,DBMET01272,6-Carboxy-etoricoxib,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,CS(=O)(=O)c1ccc(-c2cc(Cl)cnc2-c2ccc(C(=O)O)nc2)cc1,DB01628,DrugBank Augmented,0.7021276595744681,train
DB01628,Etoricoxib,DBMET01273,6-Hydroxymethyletoricoxib glucuronide,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,CS(=O)(=O)c1ccc(-c2cc(Cl)cnc2-c2ccc(COC3OC(C(=O)O)C(O)C(O)C3O)nc2)cc1,DB01628,DrugBank Augmented,0.5076923076923077,train
DB04817,Metamizole,DBMET03542,4-formyl-amino-antipyrine (FAA),Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C,Cc1c(NC=O)c(=O)n(-c2ccccc2)n1C,DB04817,DrugBank Augmented,0.4285714285714285,train
DB04817,Metamizole,DBMET03543,4-amino-antipyrine (AA),Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C,Cc1c(N)c(=O)n(-c2ccccc2)n1C,DB04817,DrugBank Augmented,0.4772727272727273,train
DB04854,Febuxostat,DBMET03281,67M-4,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,Cc1nc(-c2ccc(OCC(C)C(=O)O)c(C#N)c2)sc1C(=O)O,DB04854,DrugBank Augmented,0.8490566037735849,train
DB04855,Dronedarone,DBMET02839,"N,N'-didebutyl-dronedarone",CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN)cc1,DB04855,DrugBank Augmented,0.8095238095238095,train
DB04855,Dronedarone,DBMET02840,Phenol-dronedarone,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(O)cc1,DB04855,DrugBank Augmented,0.7096774193548387,train
DB04855,Dronedarone,DBMET02842,Propanoic acid-dronedarone,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCC(=O)O)cc1,DB04855,DrugBank Augmented,0.796875,train
DB04855,Dronedarone,DBMET02843,"Deaminated N,N′-didebutyl-dronedarone",CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCO)cc1,DB04855,DrugBank Augmented,0.8225806451612904,train
DB04896,Milnacipran,DBMET02301,Milnacipran carbamoyl O-glucuronide,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,CCN(CC)C(=O)C1(c2ccccc2)CC1CNC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,DB04896,DrugBank Augmented,0.5,train
DB04951,Pirfenidone,DBMET03219,5-Carboxy pirfenidone,Cc1ccc(=O)n(-c2ccccc2)c1,O=C(O)c1ccc(=O)n(-c2ccccc2)c1,DB04951,DrugBank Augmented,0.5625,train
DB05676,Apremilast,DBMET02625,O-desmethyl  apremilast glucuronide,CCOc1cc(C(CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,CCOc1cc(C(CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC1OC(C(=O)O)C(O)C(O)C1O,DB05676,DrugBank Augmented,0.7012987012987013,train
DB06016,Cariprazine,DBMET03492,Didesmethyl cariprazine,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,NC(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,DB06016,DrugBank Augmented,0.7636363636363637,train
DB06204,Tapentadol,DBMET03693,4-Hydroxy tapentadol glucuronide,CCC(c1cccc(O)c1)C(C)CN(C)C,CCC(c1cc(O)cc(OC2OC(C(=O)O)C(O)C(O)C2O)c1)C(C)CN(C)C,DB06204,DrugBank Augmented,0.423728813559322,train
DB06207,Silodosin,DBMET03296,KMD-3241 glucuronide,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,CC(Cc1cc(C(N)=O)c2c(ccn2CCCOC2OC(C(=O)O)C(O)C(O)C2O)c1)NCCOc1ccccc1OCC(F)(F)F,DB06207,DrugBank Augmented,0.5104166666666666,train
DB06207,Silodosin,DBMET03297,KMD-3295,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,CC(Cc1cc(C(N)=O)c2c(ccn2CCC(=O)O)c1)NCCOc1ccccc1OCC(F)(F)F,DB06207,DrugBank Augmented,0.5853658536585366,train
DB06209,Prasugrel,DBMET00483,R-138727,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,O=C(O)CC1=C(S)CCN(C(C(=O)C2CC2)c2ccccc2F)C1,DB06209,DrugBank Augmented,0.5074626865671642,train
DB06230,Nalmefene,DBMET01861,Nornalmefene 3-O-glucuronide,C=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,C=C1CCC2(O)C3Cc4ccc(OC5OC(OO)C(O)C(O)C5O)c5c4C2(CCN3)C1O5,DB06230,DrugBank Augmented,0.4025974025974026,train
DB06230,Nalmefene,DBMET01862,Nornalmefene 3-O-sulfate,C=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,C=C1CCC2(O)C3Cc4ccc(OS(=O)(=O)O)c5c4C2(CCN3)C1O5,DB06230,DrugBank Augmented,0.4305555555555556,train
DB06237,Avanafil,DBMET03271,Avanafil metabolite M16,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COc1ccc(CNc2nc(NC(CO)CCC(=O)O)ncc2C(=O)NCc2ncccn2)cc1Cl,DB06237,DrugBank Augmented,0.5697674418604651,train
DB06263,Amrubicin,DBMET02165,Amrubicin Met B,CC(=O)C1(N)Cc2c(O)c3c(c(O)c2C(OC2CC(O)C(O)CO2)C1)C(=O)c1ccccc1C3=O,CC(O)C1(N)CCc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,DB06263,DrugBank Augmented,0.4,train
DB06282,Levocetirizine,DBMET02649,Levocetirizine 4-chloro-4'-hydroxybenzhydryl Mercapturate Metabolites (M10a and M10b),O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,CC(=O)NC(CSC(c1ccc(O)cc1)c1ccc(Cl)cc1)C(=O)O,DB06282,DrugBank Augmented,0.265625,train
DB06448,Lonafarnib,DBMET03218,Lonafarnib metabolite M2,NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,NC(=O)N1C=CC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,DB06448,DrugBank Augmented,0.7571428571428571,train
DB06480,Prucalopride,DBMET02198,Desmethyl prucalopride acid,COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1,Nc1c(Cl)cc(C(=O)NC2CCN(CCC(=O)O)CC2)c2c1CCO2,DB06480,DrugBank Augmented,0.7540983606557377,train
DB06670,Odanacatib,DBMET01473,M3 (Odanacatib),CC(C)(F)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,CC(F)(COC1OC(C(=O)O)C(O)C(O)C1O)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,DB06670,DrugBank Augmented,0.6493506493506493,train
DB06670,Odanacatib,DBMET01475,M7-B (Odanacatib),CC(C)(F)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,CC(F)(C=O)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,DB06670,DrugBank Augmented,0.8333333333333334,train
DB14726,Dabigatran,DBMET03380,Dabigatran M500,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)ccc21,DB14726,DrugBank Augmented,0.5185185185185185,train
DB14726,Dabigatran,DBMET03382,Dabigatran M369,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.6716417910447762,train
DB14726,Dabigatran,DBMET03385,Dabigatran M354,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CN)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.7538461538461538,train
DB14726,Dabigatran,DBMET02414,Dabigatran 2-O-acylglucuronide metabolite,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3C(O)OC(C(=O)O)C(O)C3O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.7283950617283951,train
DB14726,Dabigatran,DBMET02415,Dabigatran 3-O-acylglucuronide metabolite,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3C(O)C(O)OC(C(=O)O)C3O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.7195121951219512,train
DB14726,Dabigatran,DBMET02416,Dabigatran 4-O-acylglucuronide metabolite,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3C(C(=O)O)OC(O)C(O)C3O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.7375,train
DB14726,Dabigatran,DBMET03387,Dabigatran M690,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3OC(C(=O)NC(N)=O)C(O)C(O)C3O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.6987951807228916,train
DB14726,Dabigatran,DBMET03388,Dabigatran M486-2,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,COC(=O)CCN(C(=O)c1ccc2c(c1)nc(CNc1ccc(C(=N)N)cc1)n2C)c1ccccn1,DB14726,DrugBank Augmented,0.8656716417910447,train
DB14726,Dabigatran,DBMET03389,Dabigatran M636,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OCC(O)C(O)C(O)C(O)CO)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.7532467532467533,train
DB06755,Beta carotene,DBMET02046,retinoic acid,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,DB06755,DrugBank Augmented,0.8,train
DB06769,Bendamustine,DBMET01424,dihydroxy-bendamustine (bendamustine metabolite HP2),Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,Cn1c(CCCC(=O)O)nc2cc(N(CCO)CCO)ccc21,DB06769,DrugBank Augmented,0.8163265306122449,train
DB06824,Triethylenetetramine,DBMET01457,"N1, N10-diacetyltriethylenetetramine",NCCNCCNCCN,CC(=O)NCCNCCNCCNC(C)=O,DB06824,DrugBank Augmented,0.2857142857142857,train
DB07565,Chloramphenicol succinate,DBMET03159,Chloramphenicol 1-acetate,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,CC(=O)OC(c1ccc([N+](=O)[O-])cc1)C(CO)NC(=O)C(Cl)Cl,DB07565,DrugBank Augmented,0.4915254237288136,train
DB07565,Chloramphenicol succinate,DBMET03163,Chloramphenicol Oxamyl Ethanolamine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(NCO)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.4482758620689655,train
DB07565,Chloramphenicol succinate,DBMET03164,Chloramphenicol Oxamyl Glycine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(O)CNC(=O)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.4745762711864407,train
DB07565,Chloramphenicol succinate,DBMET03166,Chloramphenicol Aryl Amide,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,CC(=O)Nc1ccc(C(O)C(N)CO)cc1,DB07565,DrugBank Augmented,0.2459016393442623,train
DB07565,Chloramphenicol succinate,DBMET03168,Chloramphenicol Base N-acetyl,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,CC(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.4727272727272727,train
DB08804,Nandrolone decanoate,DBMET03361,19-Norandrosterone 3-O-glucuronide,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,CC12CCC3C4CCC(OC5OC(C(=O)O)C(O)C(O)C5O)CC4CCC3C1CCC2=O,DB08804,DrugBank Augmented,0.2159090909090909,train
DB08804,Nandrolone decanoate,DBMET03362,19-Noretiocholanolone 3-O-glucuronide,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,CC12CCC3C4CCC(OC5OC(C(=O)O)C(O)C(O)C5O)CC4CCC3C1CCC2O,DB08804,DrugBank Augmented,0.25,train
DB08822,Azilsartan medoxomil,DBMET03336,Azilsartan M-II metabolite,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,O=C(O)c1cccc2[nH]c(=O)n(Cc3ccc(-c4ccccc4-c4nc(=O)o[nH]4)cc3)c12,DB08822,DrugBank Augmented,0.3736263736263736,train
DB08822,Azilsartan medoxomil,DBMET03337,Azilsartan M-I metabolite,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2C(=N)N)cc1,DB08822,DrugBank Augmented,0.5121951219512195,train
DB08860,Pitavastatin,DBMET03740,Pitavastatin lactone,O=C(O)CC(O)CC(O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,O=C1CC(O)CC(C=Cc2c(C3CC3)nc3ccccc3c2-c2ccc(F)cc2)O1,DB08860,DrugBank Augmented,0.5571428571428572,train
DB08864,Rilpivirine,DBMET01866,glucurinated form of rilpivirine (M6),Cc1cc(C=CC#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,Cc1cc(C=CN)cc(COC2OC(C(=O)O)C(O)C(O)C2O)c1Nc1ccnc(Nc2ccc(N)cc2)n1,DB08864,DrugBank Augmented,0.3928571428571428,train
DB08864,Rilpivirine,DBMET01869,glucurinated form of rilpivirine (M7),Cc1cc(C=CC#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,NC=Cc1cc(CO)c(Nc2ccnc(Nc3ccc(N)cc3)n2)c(COC2OC(C(=O)O)C(O)C(O)C2O)c1,DB08864,DrugBank Augmented,0.3333333333333333,train
DB08877,Ruxolitinib,DBMET03263,Ruxolitinib M9 metabolite,N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,N#CCC(C1CCC(=O)C1)n1cc(-c2nc[nH]c3nccc2-3)cn1,DB08877,DrugBank Augmented,0.4520547945205479,train
DB08881,Vemurafenib,DBMET01855,secondary metabolite of vemurafenib,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,O=Cc1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12,DB08881,DrugBank Augmented,0.4153846153846154,train
DB08881,Vemurafenib,DBMET01856,secondary metabolite of vemurafenib alternative,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,DB08881,DrugBank Augmented,0.5909090909090909,train
DB08882,Linagliptin,DBMET02384,Linagliptin M531(1),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC(=O)NC1CCCN(c2nc3c(c(=O)n(Cc4nc(C)c5ccccc5n4)c(=O)n3C)n2CC#CCO)C1,DB08882,DrugBank Augmented,0.6746987951807228,train
DB08882,Linagliptin,DBMET02385,Linigliptin M531(2),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(C)=O)C2O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DB08882,DrugBank Augmented,0.6547619047619048,train
DB08882,Linagliptin,DBMET02389,Linagliptin CD1790,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DB08882,DrugBank Augmented,0.8333333333333334,train
DB08893,Mirabegron,DBMET03333,Mirabegron M5 metabolite,Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1,Nc1ccc(CCNCC(O)c2ccccc2)cc1,DB08893,DrugBank Augmented,0.5370370370370371,train
DB08899,Enzalutamide,DBMET03550,N-desmethyl enzalutamide,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(N)=O)c(F)c1,DB08899,DrugBank Augmented,0.8064516129032258,train
DB08906,Fluticasone furoate,DBMET03674,M26 fluticasone furoate,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)O,DB08906,DrugBank Augmented,0.7402597402597403,train
DB08912,Dabrafenib,DBMET03511,Carboxy-dabrafenib,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,CC(C)(C(=O)O)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,DB08912,DrugBank Augmented,0.8412698412698413,train
DB08921,(4R)-limonene,DBMET01191,Uroterpenol-O-glucuronide,C=C(C)C1CC=C(C)CC1,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,DB08921,DrugBank Augmented,0.2678571428571428,train
DB08930,Dolutegravir,DBMET03561,"2,4- difluorobenzaldehyde (M5 dolutegravir)",CC1CCOC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,OCc1ccc(F)cc1F,DB08930,DrugBank Augmented,0.25,train
DB08930,Dolutegravir,DBMET01873,hydrolized form of dolutegravir (M1),CC1CCOC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,CC1CCOC2Cn3cc(C(N)=O)c(=O)c(O)c3C(=O)N12,DB08930,DrugBank Augmented,0.5846153846153846,train
DB09039,Eliglustat,DBMET03449,Genz-258162,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,CC(=O)CCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented,0.8571428571428571,train
DB09039,Eliglustat,DBMET03453,Genz-527862,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,CCC(=O)CCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented,0.8571428571428571,train
DB09039,Eliglustat,DBMET03454,Genz-682042,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented,0.7894736842105263,train
DB09042,Tedizolid phosphate,DBMET03124,Desmethyl tedizolid sulphate,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,O=C1OC(C=S(=O)(O)O)CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,DB09042,DrugBank Augmented,0.5308641975308642,train
DB09053,Ibrutinib,DBMET02024,M17,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,C=CC(=O)NCC(CCCO)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,DB09053,DrugBank Augmented,0.5,train
DB09053,Ibrutinib,DBMET02026,M20,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,C=CC(=O)NCC(CCC(=O)O)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,DB09053,DrugBank Augmented,0.5063291139240507,train
DB09053,Ibrutinib,DBMET02028,M24,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C(CCCO)CNC(=O)C(O)O,DB09053,DrugBank Augmented,0.4444444444444444,train
DB09068,Vortioxetine,DBMET01390,M0,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,Cc1cc(C(=O)O)ccc1Sc1ccccc1N1CCNCC1,DB09068,DrugBank Augmented,0.7111111111111111,train
DB09069,Trimetazidine,DBMET03346,2-desmethyltrimetazidine O-sulphate,COc1ccc(CN2CCNCC2)c(OC)c1OC,COc1ccc(CN2CCNCC2)c(OS(=O)(=O)O)c1OC,DB09069,DrugBank Augmented,0.7560975609756098,train
DB09069,Trimetazidine,DBMET03347,2-desmethyltrimetazidine O-glucuronide,COc1ccc(CN2CCNCC2)c(OC)c1OC,COc1ccc(CN2CCNCC2)c(OC2OC(C(=O)O)C(O)C(O)C2O)c1OC,DB09069,DrugBank Augmented,0.5740740740740741,train
DB09069,Trimetazidine,DBMET03349,3-desmethyltrimetazidine O-sulphate,COc1ccc(CN2CCNCC2)c(OC)c1OC,COc1ccc(CN2CCNCC2)c(OC)c1OS(=O)(=O)O,DB09069,DrugBank Augmented,0.7560975609756098,train
DB09069,Trimetazidine,DBMET03350,3-desmethyltrimetazidine O-glucuronide,COc1ccc(CN2CCNCC2)c(OC)c1OC,COc1ccc(CN2CCNCC2)c(OC)c1OC1OC(C(=O)O)C(O)C(O)C1O,DB09069,DrugBank Augmented,0.5740740740740741,train
DB09069,Trimetazidine,DBMET03351,4-desmethyltrimetazidine O-sulphate,COc1ccc(CN2CCNCC2)c(OC)c1OC,COc1c(CN2CCNCC2)ccc(OS(=O)(=O)O)c1OC,DB09069,DrugBank Augmented,0.7317073170731707,train
DB09069,Trimetazidine,DBMET03352,4-desmethyltrimetazidine O-glucuronide,COc1ccc(CN2CCNCC2)c(OC)c1OC,COc1c(CN2CCNCC2)ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c1OC,DB09069,DrugBank Augmented,0.5555555555555556,train
DB09072,Sodium oxybate,DBMET01477,Succinic Acid,O=C(O)CCCO,O=C(O)CCC(=O)O,DB09072,DrugBank Augmented,0.5333333333333333,train
DB09074,Olaparib,DBMET03441,Olaparib M12 metabolite,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,O=C(c1ccc(F)c(C(=O)N2CCN(C(=O)C3CC3)CC2)c1)c1n[nH]c(=O)c2ccccc12,DB09074,DrugBank Augmented,0.671875,train
DB09076,Umeclidinium,DBMET03680,M21 Umeclidinium,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,O=C(O)C1OC(Oc2ccc(COCC[N+]34CCC(C(O)(c5ccccc5)c5ccccc5)(CC3)CC4)cc2)C(O)C(O)C1O,DB09076,DrugBank Augmented,0.6271186440677966,train
DB09079,Nintedanib,DBMET02778,Nintedanib M4 Metabolite,COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,CN(C(=O)CN1CCNCC1)c1ccc(NC(=C2C(=O)Nc3cc(C(=O)O)ccc32)c2ccccc2)cc1,DB09079,DrugBank Augmented,0.75,train
DB09081,Idebenone,DBMET01522,QS8,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,COC1=C(OC)C(=O)C(CCCCCCCCO)=C(C)C1=O,DB09081,DrugBank Augmented,1.0,train
DB09089,Trimebutine,DBMET01504,N-didesmethyltrimebutine,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,CCC(N)(COC(=O)c1cc(OC)c(OC)c(OC)c1)c1ccccc1,DB09089,DrugBank Augmented,0.7083333333333334,train
DB09089,Trimebutine,DBMET01506,2-methylamino-2-phenylbutan-1-ol ,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,CCC(CO)(NC)c1ccccc1,DB09089,DrugBank Augmented,0.2592592592592592,train
DB09119,Eslicarbazepine acetate,DBMET01413,Eslicarbazepine-O-glucuronide,CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21,NC(=O)N1c2ccccc2CC(NC(C=O)CCC(=O)O)c2ccccc21,DB09119,DrugBank Augmented,0.4406779661016949,train
DB09167,Dosulepin,DBMET01520,Northiaden S-oxide,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CNCCC=C1c2ccccc2C[S+]([O-])c2ccccc21,DB09167,DrugBank Augmented,0.3454545454545454,train
DB09173,Butyrfentanyl,DBMET02692,4'-hydroxy-3'-methoxy-butyrfentanyl,CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(O)c(OC)c2)CC1,DB09173,DrugBank Augmented,0.7090909090909091,train
DB09173,Butyrfentanyl,DBMET02694,ω-carboxy-butyrfentanyl,CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,O=C(O)CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DB09173,DrugBank Augmented,0.8,train
DB09185,Viloxazine,DBMET03494,5-Hydroxyviloxazine glucuronide,CCOc1ccccc1OCC1CNCCO1,CCOc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1OCC1CNCCO1,DB09185,DrugBank Augmented,0.5245901639344263,train
DB09194,Etoperidone,DBMET02172,Oxo-etoperidone (M3),CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)=O)nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented,0.75,train
DB09194,Etoperidone,DBMET02175,Etoperidone M7,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCCN2CCN(c3cc(Cl)ccc3O)CC2)c1=O,DB09194,DrugBank Augmented,0.5303030303030303,train
DB09194,Etoperidone,DBMET02176,Etoperidone M8,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCCN2CCN(c3ccc(O)c(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented,0.5625,train
DB09194,Etoperidone,DBMET02177,Etoperidone M9,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCC[N+]2([O-])CC[N+]([O-])(c3cccc(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented,0.4166666666666667,train
DB09194,Etoperidone,DBMET02178,Etoperidone M15,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCC(=O)O)c1=O,DB09194,DrugBank Augmented,0.265625,train
DB09194,Etoperidone,DBMET02184,Etoperidone M13,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCc1nn(CCC(=O)OC)c(=O)n1CC,DB09194,DrugBank Augmented,0.3898305084745763,train
DB09205,Moxisylyte,DBMET01915,deacetyl-demethyl-thymoxamine,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,CNCCOc1cc(C)c(O)cc1C(C)C,DB09205,DrugBank Augmented,0.42,train
DB09205,Moxisylyte,DBMET01916,glucuronide of deacetyl-thymoxamine,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,Cc1cc(OCCN(C)C)c(C(C)C)cc1OC1OC(O)C(O)C(O)C1O,DB09205,DrugBank Augmented,0.5769230769230769,train
DB09205,Moxisylyte,DBMET01918,sulfate of deacetyl-thymoxamine,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,Cc1ccc(C(C)C)c(OCCN(C)C)c1OS(O)(O)O,DB09205,DrugBank Augmented,0.4150943396226415,train
DB09216,Tolfenamic acid,DBMET01932,N-(2-methyl-3-chloro-4-metoxyphenyl)-anthranilic acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,COc1ccc(Nc2ccccc2C(O)OC2OC(O)C(O)C(O)C2O)c(C)c1Cl,DB09216,DrugBank Augmented,0.2857142857142857,train
DB09216,Tolfenamic acid,DBMET01933,N-(2-methyl-4-hydroxyphenyl)-anthranilic acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,Cc1cc(O)ccc1Nc1ccccc1C(=O)OC1OC(O)C(O)C(O)C1O,DB09216,DrugBank Augmented,0.3050847457627119,train
DB09216,Tolfenamic acid,DBMET01936,N-(2-methyl-3-chloro-5-hydroxyphenyl)-anthranilic acid form 3,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,Cc1c(Cl)cc(OC2OC(O)C(O)C(O)C2O)cc1Nc1ccccc1C(=O)OC1CC(O)C(O)C(O)C1O,DB09216,DrugBank Augmented,0.3484848484848485,train
DB09216,Tolfenamic acid,DBMET01938,N-(2-formyl-3-chlorophenyl) anthranilic acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,O=Cc1c(Cl)cccc1Nc1ccccc1C(=O)OC1OC(O)C(O)C(O)C1O,DB09216,DrugBank Augmented,0.3684210526315789,train
DB09216,Tolfenamic acid,DBMET01939,N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)-anthranilic acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,O=C(OC1OC(O)C(O)C(O)C1O)c1ccccc1Nc1ccc(O)c(Cl)c1CO,DB09216,DrugBank Augmented,0.2903225806451613,train
DB09216,Tolfenamic acid,DBMET01940,N-(2-hydroxymethyl-3-chlorophenyl)-4-hydroxy-anthranilic acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,O=C(OC1OC(O)C(O)C(O)C1O)c1ccccc1Nc1cccc(Cl)c1CO,DB09216,DrugBank Augmented,0.3684210526315789,train
DB09227,Barnidipine,DBMET01900,M-2,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1,COC(=O)c1c(C)nc(C)c(C(=O)OC2CCNC2)c1-c1cccc([N+](=O)[O-])c1,DB09227,DrugBank Augmented,0.3855421686746988,train
DB09227,Barnidipine,DBMET01902,M-3,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1,COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1cccc([N+](=O)[O-])c1,DB09227,DrugBank Augmented,0.640625,train
DB09229,Aranidipine,DBMET01950,Aranidipine M-2,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],CCC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented,0.5636363636363636,train
DB09229,Aranidipine,DBMET01951,Aranidipine M-4,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)O)c1-c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented,0.3880597014925373,train
DB09237,Levamlodipine,DBMET02938,Levamlodipine M10 metabolite,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,CCOC(=O)c1c(COCCO)nc(C)c(C(=O)OC)c1-c1ccccc1Cl,DB09237,DrugBank Augmented,0.3835616438356164,train
DB09237,Levamlodipine,DBMET02940,Levamlodipine M4 metabolite,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,COC(=O)c1c(C)nc(CO)c(C(=O)O)c1-c1ccccc1Cl,DB09237,DrugBank Augmented,0.2777777777777778,train
DB09256,Tegafur,DB00544,Fluorouracil,O=c1[nH]c(=O)n(C2CCCO2)cc1F,O=c1[nH]cc(F)c(=O)[nH]1,DB09256,DrugBank Augmented,0.275,train
DB09300,Butylscopolamine,DBMET01510,AD12 (Scopolamine Butylbromide),CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CCCC[N+]1(C)C2CC3CC1C(O3)C2O,DB09300,DrugBank Augmented,0.3859649122807017,train
DB00322,Floxuridine,DBMET01999,5-fluorodeoxyuridine-monophosphate,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented,0.7083333333333334,train
DB00322,Floxuridine,DBMET02000,5-fluorouridine-triphosphate,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented,0.45,train
DB00295,Morphine,DBMET02018,"morphine-3,6-diglucuronide",CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,OC1OC(Oc2ccc3c4c2OC2C(OC5OC(O)C(O)C(O)C5O)C=CC5C(C3)NCCC452)C(O)C(O)C1O,DB00295,DrugBank Augmented,0.3246753246753247,train
DB11219,Enzacamene,DBMET02092,3-(4-carboxybenzylidene)camphor,Cc1ccc(C=C2C(=O)C3(C)CCC2C3(C)C)cc1,CC12CCC(C(=Cc3ccc(C(=O)O)cc3)C1=O)C2(C)C,DB11219,DrugBank Augmented,0.7,train
DB11362,Selexipag,DBMET02144,ACT-333679 glucuronide,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,CC(C)N(CCCCOCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,DB11362,DrugBank Augmented,0.5972222222222222,train
DB11586,Asunaprevir,DBMET02051,BMS-558364,C=CC1CC1(NC(=O)C1CC(Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,C=CC1CC1(NC(=O)C1CC(O)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,DB11586,DrugBank Augmented,0.6344086021505376,train
DB11637,Delamanid,DBMET01966,"(4RS,5S)-DM-6720",CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(N)=NC1O,DB11637,DrugBank Augmented,0.5526315789473685,train
DB11637,Delamanid,DBMET01968,DM-6704,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)CNC(=O)O1,DB11637,DrugBank Augmented,0.5866666666666667,train
DB11637,Delamanid,DBMET01972,DM-6706,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC(O)(CNC(N)=O)COc1ccc(N2CCC(Oc3ccc(OC(F)(F)F)cc3)CC2)cc1,DB11637,DrugBank Augmented,0.4337349397590361,train
DB11682,Daprodustat,DBMET03603,Daprodustat M13 metabolite,O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,O=C(O)CNC(=O)C1C(=O)N(C2CCC(O)C(O)C2)C(=O)N(C2CCC(O)CC2)C1O,DB11682,DrugBank Augmented,0.4444444444444444,train
DB11682,Daprodustat,DBMET03605,Daprodustat M4 metabolite,O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,O=C(O)CNC(=O)C1C(=O)N(C2CCCC(O)C2)C(=O)N(C2CCC(O)CC2)C1O,DB11682,DrugBank Augmented,0.4814814814814814,train
DB11689,Selumetinib,DBMET03099,M15 (AZ13326637),Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)O)cc21,DB11689,DrugBank Augmented,0.7142857142857143,train
DB11689,Selumetinib,DBMET03101,"M12 (Primary amide, N-demethylated selumetinib metabolite)",Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,NC(=O)c1cc2[nH]cnc2c(F)c1Nc1ccc(Br)cc1Cl,DB11689,DrugBank Augmented,0.4657534246575342,train
DB11689,Selumetinib,DBMET03103,M11 (N-demethylated carboxylic acid selumetinib metabolite),Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,O=C(O)CONC(=O)c1cc2[nH]cnc2c(F)c1Nc1ccc(Br)cc1Cl,DB11689,DrugBank Augmented,0.5540540540540541,train
DB11703,Acalabrutinib,DBMET02879,Acalabrutinib M16 Metabolite,CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,CC#CC(=O)NCCCC(O)c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,DB11703,DrugBank Augmented,0.5833333333333334,train
DB11703,Acalabrutinib,DBMET02880,Acalabrutinib M3 Metabolite,CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,Nc1nccn2c(C(=O)CCC(=O)O)nc(-c3ccc(C(=O)Nc4ccccn4)cc3)c12,DB11703,DrugBank Augmented,0.5641025641025641,train
DB11703,Acalabrutinib,DBMET02881,Acalabrutinib M2 Metabolite,CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,CC#CC(=O)NCCCC(=O)c1nc(-c2ccc(C(=O)O)cc2)c2c(N)nccn12,DB11703,DrugBank Augmented,0.4352941176470588,train
DB11703,Acalabrutinib,DBMET02883,Acalabrutinib M45 Metabolite,CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,CC(O)CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,DB11703,DrugBank Augmented,0.7631578947368421,train
DB11703,Acalabrutinib,DBMET02884,Acalabrutinib M24 Metabolite,CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,CCCC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,DB11703,DrugBank Augmented,0.7733333333333333,train
DB11703,Acalabrutinib,DBMET02886,Acalabrutinib M7 Metabolite (ACP-5531),CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,CC(=CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SCC(N)C(=O)NCC(=O)O,DB11703,DrugBank Augmented,0.7011494252873564,train
DB11739,Vonoprazan,DBMET03565,M-II,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,O=C(O)c1c[nH]c(-c2ccccc2F)c1,DB11739,DrugBank Augmented,0.238095238095238,train
DB11757,Istradefylline,DBMET02751,M1 Sulfate Conjugate (M4),CCn1c(=O)c2c(nc(C=Cc3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,CCn1c(=O)c2c(nc(C=Cc3ccc(OS(=O)(=O)O)c(OC)c3)n2C)n(CC)c1=O,DB11757,DrugBank Augmented,0.8181818181818182,train
DB11757,Istradefylline,DBMET02752,M1 Glucuronide (M5),CCn1c(=O)c2c(nc(C=Cc3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,CCn1c(=O)c2c(nc(C=Cc3ccc(OC4OC(C(=O)O)C(O)C(O)C4O)c(OC)c3)n2C)n(CC)c1=O,DB11757,DrugBank Augmented,0.6818181818181818,train
DB11763,Momelotinib,DBMET03718,Momelotinib M16 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(NCCO)cc3)n2)cc1,DB11763,DrugBank Augmented,0.6666666666666666,train
DB11763,Momelotinib,DBMET03710,Momelotinib M28 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,NC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented,0.5507246376811594,train
DB11763,Momelotinib,DBMET03712,Momelotinib M8 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,NC(=O)CNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented,0.6056338028169014,train
DB11763,Momelotinib,DBMET03711,Momelotinib M14 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,O=C(O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented,0.5671641791044776,train
DB11793,Niraparib,DBMET03568,Niraparib M10 metabolite,NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12,DB11793,DrugBank Augmented,0.6323529411764706,train
DB11827,Ertugliflozin,DBMET01907,Ertugliflozin M5a metabolite,CCOc1ccc(Cc2cc(C34OCC(CO)(O3)C(O)C(O)C4O)ccc2Cl)cc1,O=C(O)C1OC(OC2C(O)C(O)C3(c4ccc(Cl)c(Cc5ccc(O)cc5)c4)OCC2(CO)O3)C(O)C(O)C1O,DB11827,DrugBank Augmented,0.5333333333333333,train
DB11827,Ertugliflozin,DBMET01908,Ertugliflozin M5b metabolite,CCOc1ccc(Cc2cc(C34OCC(CO)(O3)C(O)C(O)C4O)ccc2Cl)cc1,O=C(O)C1OC(OC2C(O)C3(CO)COC(c4ccc(Cl)c(Cc5ccc(O)cc5)c4)(O3)C2O)C(O)C(O)C1O,DB11827,DrugBank Augmented,0.5616438356164384,train
DB11901,Apalutamide,DBMET03639,M4 apalutamide,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(C(=O)O)c(F)c3)C2=S)cc1C(F)(F)F,DB11901,DrugBank Augmented,0.8260869565217391,train
DB11915,Valbenazine,DBMET03700,9-O-desmethyl-dihydrotetrabenazine,COc1cc2c(cc1OC)C1CC(OC(=O)C(N)C(C)C)C(CC(C)C)CN1CC2,COc1cc2c(cc1O)C1CC(O)C(CC(C)C)CN1CC2,DB11915,DrugBank Augmented,0.5873015873015873,train
DB11915,Valbenazine,DBMET03701,10-O-desmethyl-dihydrotetrabenazine,COc1cc2c(cc1OC)C1CC(OC(=O)C(N)C(C)C)C(CC(C)C)CN1CC2,COc1cc2c(cc1O)CCN1CC(CC(C)C)C(O)CC21,DB11915,DrugBank Augmented,0.5873015873015873,train
DB11986,Entrectinib,DBMET02747,ENB579b,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,C[N+]1([O-])CCN(c2ccc(C(O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,DB11986,DrugBank Augmented,0.6206896551724138,train
DB11986,Entrectinib,DBMET02749,ENB753,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1OC1OC(C(=O)O)C(O)C(O)C1O,DB11986,DrugBank Augmented,0.7111111111111111,train
DB12010,Fostamatinib,DBMET02095,R529,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1O,DB12010,DrugBank Augmented,0.5487804878048781,train
DB12010,Fostamatinib,DBMET02096,R406 N-glucuronide,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,DB12010,DrugBank Augmented,0.6292134831460674,train
DB12265,Fexinidazole,DBMET03403,Fexinidazole sulfone metabolite (M2),CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Cn1c([N+](=O)[O-])cnc1COc1ccc(S(C)(=O)=O)cc1,DB12265,DrugBank Augmented,0.6956521739130435,train
DB12332,Rucaparib,DBMET03520,Rucaparib M337a metabolite,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,CN1CCc2c(-c3ccc(C(N)=O)cc3)[nH]c3cc(F)cc(c23)C1=O,DB12332,DrugBank Augmented,0.4615384615384615,train
DB12332,Rucaparib,DBMET03521,Rucaparib M337c metabolite,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,Cn1c(-c2ccc(C(N)=O)cc2)c2c3c(cc(F)cc31)C(=O)NCC2,DB12332,DrugBank Augmented,0.4242424242424242,train
DB12364,Betrixaban,DBMET01537,PRT062799,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,Nc1ccc(O)cc1C(=O)Nc1ccc(Cl)cn1,DB12364,DrugBank Augmented,0.4426229508196721,train
DB12364,Betrixaban,DBMET01538,PRT062982,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,COc1cc(O)c(N)c(C(=O)Nc2ccc(Cl)cn2)c1,DB12364,DrugBank Augmented,0.5409836065573771,train
DB13609,Umifenovir,DBMET03050,Arbidol M9-1 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CSc2ccccc2)[nH]c2cc(Br)c(OS(=O)(=O)O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.5131578947368421,train
DB13609,Umifenovir,DBMET03051,Arbidol M13-1 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CO)n(C)c2cc(Br)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.4936708860759494,train
DB13609,Umifenovir,DBMET03052,Arbidol M13-2 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(COC2OC(C(=O)O)C(O)C(O)C2O)n(C)c2cc(Br)c(O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.5945945945945946,train
DB13609,Umifenovir,DBMET03053,Arbidol M17-2 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(CNC)c12,DB13609,DrugBank Augmented,0.5432098765432098,train
DB13609,Umifenovir,DBMET03054,Arbidol M19 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(C[S+]([O-])c2ccccc2)n(C)c2cc(Br)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(CNC)c12,DB13609,DrugBank Augmented,0.4,train
DB13609,Umifenovir,DBMET03055,Arbidol M20 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(C[S+]([O-])c2ccccc2)n(C)c2cc(Br)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.5,train
DB13609,Umifenovir,DBMET03056,Arbidol M21 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CS(=O)(=O)c2ccccc2)n(C)c2cc(Br)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(CNC)c12,DB13609,DrugBank Augmented,0.4,train
DB13609,Umifenovir,DBMET03057,Arbidol M22 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CS(=O)(=O)c2ccccc2)n(C)c2cc(Br)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.5,train
DB13609,Umifenovir,DBMET03058,Arbidol M9-2 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(OS(=O)(=O)O)c(CNC)c12,DB13609,DrugBank Augmented,0.6111111111111112,train
DB13609,Umifenovir,DBMET03059,Arbidol M11-2 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(C[S+]([O-])c2ccccc2)n(C)c2cc(Br)c(OS(=O)(=O)O)c(CNC)c12,DB13609,DrugBank Augmented,0.4444444444444444,train
DB13609,Umifenovir,DBMET03060,Arbidol M14-1 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(C[S+]([O-])c2ccccc2)n(C)c2cc(Br)c(OS(=O)(=O)O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.56,train
DB13609,Umifenovir,DBMET03061,Arbidol M15 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CS(=O)(=O)c2ccccc2)n(C)c2cc(Br)c(OS(=O)(=O)O)c(CNC)c12,DB13609,DrugBank Augmented,0.4556962025316455,train
DB13609,Umifenovir,DBMET03062,Arbidol M16 metabolite,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,CCOC(=O)c1c(CS(=O)(=O)c2ccccc2)n(C)c2cc(Br)c(OS(=O)(=O)O)c(CN(C)C)c12,DB13609,DrugBank Augmented,0.5753424657534246,train
DB13941,Piperaquine,DBMET01948,M5 (piperaquine),Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1,[O-][n+]1ccc(N2CCN(CCCN3CCN(c4cc[n+]([O-])c5cc(Cl)ccc45)CC3)CC2)c2ccc(Cl)cc21,DB13941,DrugBank Augmented,0.5625,train
DB13960,Bronopol,DBMET02074,Bromonitromethane,O=[N+]([O-])C(Br)(CO)CO,O=[N+]([O-])CBr,DB13960,DrugBank Augmented,0.3333333333333333,train
DB14185,Aripiprazole lauroxil,DB01238,Aripiprazole,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,DB14185,DrugBank Augmented,0.5641025641025641,train
DB14512,Mometasone furoate,DBMET02367,"21-chloro-17-alpha-hydroxy-16-alpha-methyl-9-beta,11-beta-oxidopregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,CC1CC2C3CCC4=CC(=O)C=CC4(C)C34OC4CC2(C)C1(O)C(=O)CCl,DB14512,DrugBank Augmented,0.4819277108433735,train
DB14512,Mometasone furoate,DBMET02369,"21-beta-chloro-21-alpha-hydroxy-16-alpha-methyl-9-beta,11-beta-oxidopregna-1,4,17,20-tetraen-3-one 21-(2-furoate",CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,CC1CC2C3CCC4=CC(=O)C=CC4(C)C34OC4CC2(C)C1=C=C(Cl)OC(=O)c1ccco1,DB14512,DrugBank Augmented,0.4516129032258064,train
DB14761,Remdesivir,DBMET03215,Remdesivir cyclic anhydride,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,CC1NP(=O)(OCC2OC(C#N)(c3ccc4c(N)ncnn34)C(O)C2O)OC1=O,DB14761,DrugBank Augmented,0.5,train
DB14761,Remdesivir,DBMET03036,Remdesivir Nucleoside Monophosphate,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(COP(=O)(O)O)C(O)C1O,DB14761,DrugBank Augmented,0.5975609756097561,train
DB14921,Mavacamten,DBMET03498,MYK-2210 glucuronide,CC(Nc1cc(=O)n(C(C)C)c(=O)[nH]1)c1ccccc1,CC(Nc1cc(=O)n(C(C)C)c(=O)[nH]1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1,DB14921,DrugBank Augmented,0.5517241379310345,train
DB16165,Finerenone,DBMET03396,Finerenone M2 Metabolite,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCOc1ncc(CO)c2nc(C)c(C(N)=O)c(-c3ccc(C#N)cc3OC)c12,DB16165,DrugBank Augmented,0.4444444444444444,train
DB16165,Finerenone,DBMET03400,Finerenone M5 Metabolite,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCOc1ncc(CO)c2c1C(c1ccc(C#N)cc1OC)C(O)(C(N)=O)C(C)(O)N2,DB16165,DrugBank Augmented,0.5512820512820513,train
DB16200,Iptacopan,DBMET03747,M9 iptacopan,CCOC1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)C(c2ccc(C(=O)O)cc2)C1,COc1cc(C)c2[nH]ccc2c1CN1CCC(O)CC1c1ccc(C(=O)OC2OC(C(C)=O)C(O)C(O)C2O)cc1,DB16200,DrugBank Augmented,0.6097560975609756,train
DB16217,Leniolisib,DBMET03656,Leniolisib M48 metabolite,CCC(=O)N1CCC(Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,Nc1ncnc2c1CN(c1cnc(O)c(C(F)(F)F)c1)CC2,DB16217,DrugBank Augmented,0.4155844155844156,train
DB16629,Serdexmethylphenidate,DBMET03283,p-hydroxy-ritalinic acid,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,O=C(O)C(c1ccc(O)cc1)C1CCCCN1,DB16629,DrugBank Augmented,0.240506329113924,train
DB16629,Serdexmethylphenidate,DBMET03282,oxo-Ritalinic acid,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,O=C1CCCC(C(C(=O)O)c2ccccc2)N1,DB16629,DrugBank Augmented,0.2933333333333333,train
DB00126,Ascorbic acid,DBMET03076,Threosone,O=C1OC(C(O)CO)C(O)=C1O,O=CC(=O)C(O)CO,DB00126,DrugBank Augmented,0.2,train
DB00126,Ascorbic acid,DBMET03077,Erythrulose,O=C1OC(C(O)CO)C(O)=C1O,O=C(CO)C(O)CO,DB00126,DrugBank Augmented,0.2121212121212121,train
DB00130,L-Glutamine,DB00129,Ornithine,NC(=O)CCC(N)C(=O)O,NCCCC(N)C(=O)O,DB00130,DrugBank Augmented,0.52,train
DB00242,Cladribine,DBMET00677,Cladribine triphosphate,Nc1nc(Cl)nc2c1ncn2C1CC(O)C(CO)O1,Nc1nc(Cl)nc2c1ncn2C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1,DB00242,DrugBank Augmented,0.6610169491525424,train
DB00250,Dapsone,DBMET01045,Dapsone mercaptal intermediate,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,Nc1ccc(S(=O)(=O)c2ccc(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)cc2)cc1,DB00250,DrugBank Augmented,0.2711864406779661,train
DB00313,Valproic acid,DBMET01108,2-Propylsuccinic acid,CCCC(CCC)C(=O)O,CCCC(CC(=O)O)C(=O)O,DB00313,DrugBank Augmented,0.7142857142857143,train
DB00315,Zolmitriptan,DBMET03121,Indole acetic acid zolmitriptan derivative,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,O=C(O)Cc1c[nH]c2ccc(CC3COC(=O)N3)cc12,DB00315,DrugBank Augmented,0.6981132075471698,train
DB00352,Tioguanine,DBMET01155,Thioguanosine triphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C3O)c2[nH]1,DB00352,DrugBank Augmented,0.2205882352941176,train
DB00352,Tioguanine,DBMET01156,Thiodeoxyguanosine diphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3CC(O)C(COP(=O)(O)OP(=O)(O)O)O3)c2[nH]1,DB00352,DrugBank Augmented,0.2238805970149253,train
DB00409,Remoxipride,DBMET03196,Remoxipride Metabolite NCM 009,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1(O)CCC(=O)N1,DB00409,DrugBank Augmented,0.4761904761904761,train
DB00412,Rosiglitazone,DBMET00937,N-Desmethyl-ortho-O-sulfate rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ncccc3OS(=O)(=O)O)cc2)S1,DB00412,DrugBank Augmented,0.5,train
DB00412,Rosiglitazone,DBMET01113,N-Desmethyl para-O-sulfate rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ccc(OS(=O)(=O)O)cn3)cc2)S1,DB00412,DrugBank Augmented,0.4696969696969697,train
DB00421,Spironolactone,DBMET02484,3alpha-hydroxythiomethylspironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,CSC1CC2=CC(O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,DB00421,DrugBank Augmented,0.6031746031746031,train
DB00421,Spironolactone,DBMET03697,6-beta-7-alpha-thiomethylspironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,CSC1C(O)C2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,DB00421,DrugBank Augmented,0.5692307692307692,train
DB00441,Gemcitabine,DBMET00859,Gemcitabine triphosphate,Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1,Nc1ccn(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)c(=O)n1,DB00441,DrugBank Augmented,0.6428571428571429,train
DB00461,Nabumetone,DBMET02523,6-hydroxy-naphthylacetic acid,COc1ccc2cc(CCC(C)=O)ccc2c1,O=C(O)Cc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented,0.3414634146341463,train
DB00461,Nabumetone,DBMET02529,6-methoxy-naphthylacetic acid glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,COc1ccc2cc(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.4150943396226415,train
DB00461,Nabumetone,DBMET02531,reduced O-desmethyl-3-hydroxy-nabumetone,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented,0.2888888888888888,train
DB00461,Nabumetone,DBMET02538,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated),COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.3508771929824561,train
DB00461,Nabumetone,DBMET02541,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated),COc1ccc2cc(CCC(C)=O)ccc2c1,CC(CCc1ccc2cc(O)ccc2c1)OC1OC(C(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented,0.3,train
DB00461,Nabumetone,DBMET02546,4-(6-Hydroxy-2-naphthyl)- butan-2-one glucuronide glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(=O)CCc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.4642857142857143,train
DB00470,Dronabinol,DBMET03558,11-nor-9-carboxy-delta-9-THC-glucuronide,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)=CC21,DB00470,DrugBank Augmented,0.5833333333333334,train
DB00472,Fluoxetine,DBMET01364,Norfluoxetine acid,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,O=C(O)CC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,DB00472,DrugBank Augmented,0.6046511627906976,train
DB00476,Duloxetine,DBMET02507,"5-hydroxy, 6-methoxy duloxetine",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(O)c(OC)ccc12)c1cccs1,DB00476,DrugBank Augmented,0.68,train
DB00482,Celecoxib,DBMET00813,Celecoxib glucuronide,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc2)cc1,DB00482,DrugBank Augmented,0.5645161290322581,train
DB00531,Cyclophosphamide,DBMET01147,Phosphoramide Mustard,O=P1(N(CCCl)CCCl)NCCCO1,NP(=O)(O)N(CCCl)CCCl,DB00531,DrugBank Augmented,0.2105263157894736,train
DB00549,Zafirlukast,DBMET01252,Zafirlukast metabolite M4,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(CO)c2ccc(NC(C)=O)cc12,DB00549,DrugBank Augmented,0.6666666666666666,train
DB00549,Zafirlukast,DBMET01253,Zafirlukast metabolite M3,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1c[nH]c2ccc(NC(C)=O)cc12,DB00549,DrugBank Augmented,0.5903614457831325,train
DB00564,Carbamazepine,DBMET00684,2-hydroxyiminostilbene,NC(=O)N1c2ccccc2C=Cc2ccccc21,Oc1ccc2c(c1)C=Cc1ccccc1N2,DB00564,DrugBank Augmented,0.2631578947368421,train
DB00574,Fenfluramine,DBMET03180,1-(3-trifluoromethyl-phenyl)-propan-2-ol,CCNC(C)Cc1cccc(C(F)(F)F)c1,CC(O)Cc1cccc(C(F)(F)F)c1,DB00574,DrugBank Augmented,0.6216216216216216,train
DB00574,Fenfluramine,DBMET03181,"1-(3-trifluoromethyl-phenyl)-propan-1,2-diol",CCNC(C)Cc1cccc(C(F)(F)F)c1,CC(O)C(O)c1cccc(C(F)(F)F)c1,DB00574,DrugBank Augmented,0.4047619047619047,train
DB00580,Valdecoxib,DBMET01341,Valdecoxib metabolite M8,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)(=O)O)cc1,DB00580,DrugBank Augmented,0.75,train
DB00582,Voriconazole,DBMET01186,"UK-215,364",CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,OC(Cn1cncn1)c1ccc(F)cc1F,DB00582,DrugBank Augmented,0.423728813559322,train
DB00598,Labetalol,DBMET02677,Labetalol Glucuronide Metabolite (X),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,CC(CCc1ccccc1)n1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)c(O)c(C(N)=O)c21,DB00598,DrugBank Augmented,0.2857142857142857,train
DB00598,Labetalol,DBMET02678,Labetalol Glucuronide Metabolite (XI),CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,CC(CCc1ccccc1)n1ccc2cc(O)c(OC3OC(C(=O)O)C(O)C(O)C3O)c(C(N)=O)c21,DB00598,DrugBank Augmented,0.3170731707317073,train
DB00608,Chloroquine,DBMET03064,7-chloro-4-aminoquinoline,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,Nc1ccnc2cc(Cl)ccc12,DB00608,DrugBank Augmented,0.38,train
DB15566,Prednisolone acetate,DBMET02855,"6β,11β,17α,20β,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented,0.3376623376623376,train
DB00675,Tamoxifen,DBMET02700,4-endoxifen Sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.56,train
DB00675,Tamoxifen,DBMET02715,Tamoxifen Metabolite Y,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(OCCO)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.717948717948718,train
DB00675,Tamoxifen,DBMET02719,"Norendoxifen (4-hydroxy-N,N-didesmethyltamoxifen)",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCN)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.6363636363636364,train
DB00755,Tretinoin,DBMET03632,4-Oxoretinoic acid glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(CO)C(O)C(O)C1O,DB00755,DrugBank Augmented,0.4202898550724637,train
DB00770,Alprostadil,DBMET03614,"13,14-dihydro-PGE1",CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,CCCCCC(O)CCC1C(O)CC(=O)C1CCCCCCC(=O)O,DB00770,DrugBank Augmented,0.6363636363636364,train
DB01420,Testosterone propionate,DBMET03005,17-Epiestriol,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3c4ccc(O)cc4CCC3C1CC(O)C2O,DB01420,DrugBank Augmented,0.2428571428571428,train
DB00808,Indapamide,DBMET01333,Indapamide metabolite M2,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CC1C(=O)c2cc(O)ccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,DB00808,DrugBank Augmented,0.5645161290322581,train
DB00949,Felbamate,DBMET01095,Atropaldehyde,NC(=O)OCC(COC(N)=O)c1ccccc1,C=C(C=O)c1ccccc1,DB00949,DrugBank Augmented,0.2285714285714285,train
DB00949,Felbamate,DBMET01097,3-Carbamoyl-2-phenylpropionic acid,NC(=O)OCC(COC(N)=O)c1ccccc1,NC(=O)OCC(C(=O)O)c1ccccc1,DB00949,DrugBank Augmented,0.6666666666666666,train
DB00997,Doxorubicin,DBMET03628,4-O-demethyl deoxaglycone doxorubicinol,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented,0.2988505747126437,train
DB01006,Letrozole,DBMET02983,Letrozole carbinol glucuronide metabolite,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,N#Cc1ccc(C(OC2OC(C(=O)O)C(O)C(O)C2O)c2ccc(C#N)cc2)cc1,DB01006,DrugBank Augmented,0.2941176470588235,train
DB01015,Sulfamethoxazole,DBMET01050,Sulfamethoxazole GSH conjugate,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,Cc1cc(NS(=O)(=O)c2ccc(N[S+]([O-])SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)cc2)no1,DB01015,DrugBank Augmented,0.3835616438356164,train
DB01026,Ketoconazole,DBMET02659,M15 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Nc1ccc(OCC2COC(Cn3ccnc3)(c3ccc(Cl)cc3Cl)O2)cc1,DB01026,DrugBank Augmented,0.7222222222222222,train
DB01026,Ketoconazole,DBMET02662,Ketoconazole ketone hydroxyl intermediate,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C(=O)CNC4O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.6875,train
DB01026,Ketoconazole,DBMET02666,M5' (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NC(=O)C4=O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.7088607594936709,train
DB01026,Ketoconazole,DBMET02667,M3 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CNC=N)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.6883116883116883,train
DB01029,Irbesartan,DBMET01056,Irbesartan derivative M2,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented,0.6164383561643836,train
DB01060,Amoxicillin,DBMET03001,Amoxicillin M5 Metabolite,CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O,CC1(C(=O)O)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O,DB01060,DrugBank Augmented,0.8113207547169812,train
DB01068,Clonazepam,DBMET03608,3-hydroxy-7-acetamido-clonazepam,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,CC(=O)Nc1ccc2c(c1)C(c1ccccc1Cl)=NC(O)C(=O)N2,DB01068,DrugBank Augmented,0.3692307692307692,train
DB00322,Floxuridine,DBMET03589,5-fluorouridine diphosphate (5-FUDP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented,0.4655172413793103,train
DB01156,Bupropion,DBMET03482,"S,S-Hydroxybupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC1NC(C)(C)COC1(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented,0.2083333333333333,train
DB01222,Budesonide,DBMET00353,16-alpha-hydroxyprednisolone,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CC(O)C2(O)C(=O)CO,DB01222,DrugBank Augmented,0.6086956521739131,train
DB01235,Levodopa,DBMET02442,Homovanillic acid,NC(Cc1ccc(O)c(O)c1)C(=O)O,COc1cc(CC(=O)O)ccc1O,DB01235,DrugBank Augmented,0.3414634146341463,train
DB01242,Clomipramine,DBMET01074,2-hydroxydesmethyl clomipramine glucuronide,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CNCCCN1c2cc(Cl)c(O)cc2CCc2c(OC3OC(C(=O)O)C(O)C(O)C3O)cccc21,DB01242,DrugBank Augmented,0.2804878048780488,train
DB01242,Clomipramine,DBMET01075,8-hyroxydesmethyl clomipramine glucuronide,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CNCCCN1c2cc(Cl)ccc2CCc2c1ccc(O)c2OC1OC(C(=O)O)C(O)C(O)C1O,DB01242,DrugBank Augmented,0.3376623376623376,train
DB01275,Hydralazine,DBMET02823,3-hydroxy-methyltriazolophthalazine,NNc1nncc2ccccc12,OCc1nnc2c3ccccc3cnn12,DB01275,DrugBank Augmented,0.3023255813953488,train
DB01283,Lumiracoxib,DBMET01276,Lumiracoxib metabolite M15,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)c1ccc2c(c1)CC(=O)N2c1c(F)cccc1Cl,DB01283,DrugBank Augmented,0.2857142857142857,train
DB01283,Lumiracoxib,DBMET01283,Lumiracoxib metabolite M25 glucuronide (M20),Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,Cc1ccc2c(c1)CC(=O)N2c1c(F)cc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1Cl,DB01283,DrugBank Augmented,0.2375,train
DB01283,Lumiracoxib,DBMET01285,4'-Hydroxy-5-carboxylumiracoxib (M5),Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(C(=O)O)ccc1Nc1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented,0.5192307692307693,train
DB01355,Hexobarbital,DBMET01215,Hexobarbital glutathione conjugate derivative,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,CN1C(=O)NC(=O)C(C)(C2(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)CCCC(=O)C2)C1=O,DB01355,DrugBank Augmented,0.2435897435897435,train
DB04817,Metamizole,DBMET03544,4-acetyl-amino-antipyrine (AAA),Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C,CC(=O)Nc1c(C)n(C)n(-c2ccccc2)c1=O,DB04817,DrugBank Augmented,0.4583333333333333,train
DB04855,Dronedarone,DBMET02841,Phenol-dronedarone glucuronide,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OC2C(O)C(O)C(O)C(O)C2C(=O)O)cc1,DB04855,DrugBank Augmented,0.6666666666666666,train
DB04855,Dronedarone,DBMET02844,"Deaminated N,N′-didebutyl-dronedarone glucuronide",CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCOC2C(O)C(O)C(O)C(O)C2C(=O)O)cc1,DB04855,DrugBank Augmented,0.6986301369863014,train
DB06670,Odanacatib,DBMET01474,M7-A (Odanacatib),CC(C)(F)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,CC1(F)CC(C(=O)NC2(C#N)CC2)N(C(c2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)C(F)(F)F)C1O,DB06670,DrugBank Augmented,0.5135135135135135,train
DB14726,Dabigatran,DBMET03383,Dabigatran M325,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1cnc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented,0.6119402985074627,train
DB14726,Dabigatran,DBMET03386,Dabigatran M396,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,CC(=O)NCc1nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc2n1C,DB14726,DrugBank Augmented,0.7575757575757576,train
DB07565,Chloramphenicol succinate,DBMET03160,"Chloramphenicol 1,3-diacetate",O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,CC(=O)OCC(NC(=O)C(Cl)Cl)C(OC(C)=O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented,0.5517241379310345,train
DB08860,Pitavastatin,DBMET03741,M3 pitavastatin,O=C(O)CC(O)CC(O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,O=C(O)CC(O)CC(=O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,DB08860,DrugBank Augmented,0.7580645161290323,train
DB08882,Linagliptin,DBMET02390,Linagliptin M490(1),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Cc1nc(Cn2c(=O)c3c(nc(N4CCCC(O)C4)n3CC#CCO)n(C)c2=O)nc2ccccc12,DB08882,DrugBank Augmented,0.7272727272727273,train
DB08882,Linagliptin,DBMET02391,Linagliptin M506(1),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(NCCCC(O)C(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DB08882,DrugBank Augmented,0.5581395348837209,train
DB08899,Enzalutamide,DBMET03551,Carboxyl metabolite enzalutamide (M1),CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)O)c(F)c1,DB08899,DrugBank Augmented,0.819672131147541,train
DB08912,Dabrafenib,DBMET03512,Desmethyl-dabrafenib,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,DB08912,DrugBank Augmented,0.75,train
DB09039,Eliglustat,DBMET03450,Genz-399207,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented,0.8392857142857143,train
DB09039,Eliglustat,DBMET03451,Genz-399240,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented,0.8214285714285714,train
DB09081,Idebenone,DBMET01523,QS6,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,COC1=C(OC)C(=O)C(CCCCCCO)=C(C)C1=O,DB09081,DrugBank Augmented,1.0,train
DB09089,Trimebutine,DBMET01507,2-amino-2-phenylbutan-1-ol,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,CCC(N)(CO)c1ccccc1,DB09089,DrugBank Augmented,0.32,train
DB09194,Etoperidone,DBMET02173,Etoperidone M16,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)=O)nn(CCC(=O)OC)c1=O,DB09194,DrugBank Augmented,0.2615384615384615,train
DB09205,Moxisylyte,DBMET01917,glucuronide of deacetyl-demethyl-thymoxamine,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,CNCCOc1c(C(C)C)ccc(C)c1OC1OC(O)C(O)C(O)C1O,DB09205,DrugBank Augmented,0.2272727272727272,train
DB09205,Moxisylyte,DBMET01919,sulfate of deacetyl-demethyl-thymoxamine,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,CNCCOc1c(C(C)C)ccc(C)c1OS(O)(O)O,DB09205,DrugBank Augmented,0.2586206896551724,train
DB09216,Tolfenamic acid,DBMET01941,N-(2-carboxy-3-chlorophenyl)-anthranilic acid,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,O=C(OC1OC(O)C(O)C(O)C1O)c1ccccc1Nc1cccc(Cl)c1C(=O)O,DB09216,DrugBank Augmented,0.4259259259259259,train
DB09227,Barnidipine,DBMET01903,M-4,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1,COC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1cccc([N+](=O)[O-])c1,DB09227,DrugBank Augmented,0.3552631578947368,train
DB09229,Aranidipine,DBMET01953,Aranidipine M-5,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],COC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented,0.3870967741935484,train
DB09237,Levamlodipine,DBMET02941,Levamlodipine M12 metabolite,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,CCOC(=O)c1c(COCC(=O)O)nc(C)c(C(=O)OC)c1-c1ccccc1Cl,DB09237,DrugBank Augmented,0.3466666666666667,train
DB11219,Enzacamene,DBMET02093,3-(4-carboxybenzylidene)-6-hydroxycamphor,Cc1ccc(C=C2C(=O)C3(C)CCC2C3(C)C)cc1,CC12CC(O)C(C(=Cc3ccc(C(=O)O)cc3)C1=O)C2(C)C,DB11219,DrugBank Augmented,0.4285714285714285,train
DB11637,Delamanid,DBMET01967,(S)-DM-6718,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=N)NC1=O,DB11637,DrugBank Augmented,0.5584415584415584,train
DB11637,Delamanid,DBMET01969,"(4R,5S)-DM-6721",CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=O)NC1O,DB11637,DrugBank Augmented,0.5526315789473685,train
DB11703,Acalabrutinib,DBMET02887,Acalabrutinib M10 Metabolite (ACP-5461),CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,CC(=CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SCC(N)C(=O)O,DB11703,DrugBank Augmented,0.7439024390243902,train
DB11763,Momelotinib,DBMET03719,Momelotinib M17 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N)cc3)n2)cc1,DB11763,DrugBank Augmented,0.7,train
DB12010,Fostamatinib,DBMET02097,R529 O-glucuronide,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC1OC(C(=O)O)C(O)C(O)C1O,DB12010,DrugBank Augmented,0.5052631578947369,train
DB12010,Fostamatinib,DBMET02098,R529 Sulfate-conjugate,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OS(=O)(=O)O,DB12010,DrugBank Augmented,0.5529411764705883,train
DB12010,Fostamatinib,DBMET02099,"3,5 benzene diol metabolite of R406",COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC1(C)Oc2ccc(Nc3nc(Nc4cc(O)cc(O)c4)ncc3F)nc2NC1=O,DB12010,DrugBank Augmented,0.4698795180722891,train
DB12364,Betrixaban,DBMET01539,PRT063069,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,COc1cc(OS(O)(O)O)c(N)c(C(=O)Nc2ccc(Cl)cn2)c1,DB12364,DrugBank Augmented,0.4848484848484848,train
DB14761,Remdesivir,DBMET03035,Remdesivir Alanine Metabolite (Ala-Met; GS-704277),CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,CC(NP(=O)(O)OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)C(=O)O,DB14761,DrugBank Augmented,0.6627906976744186,train
DB14761,Remdesivir,DB15686,GS-441524,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(CO)C(O)C1O,DB14761,DrugBank Augmented,0.5,train
DB14761,Remdesivir,DBMET03038,Remdesivir Nucleoside Triphosphate,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(COP(=O)(O)O[PH](=O)(=O)O[PH](=O)(=O)O)C(O)C1O,DB14761,DrugBank Augmented,0.532608695652174,train
DB16165,Finerenone,DBMET03397,Finerenone M3 Metabolite,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCOc1ncc(C(=O)O)c2nc(C)c(C(N)=O)c(-c3ccc(C#N)cc3OC)c12,DB16165,DrugBank Augmented,0.4444444444444444,train
DB16165,Finerenone,DBMET03401,Finerenone M8 Metabolite,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCOc1ncc(C(=O)O)c2c1C(c1ccc(C#N)cc1OC)C(O)(C(N)=O)C(C)(O)N2,DB16165,DrugBank Augmented,0.5512820512820513,train
DB00250,Dapsone,DBMET01046,Dapsone GSH conjugate,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,Nc1ccc(S(=O)(=O)c2ccc(N[S+]([O-])SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)cc2)cc1,DB00250,DrugBank Augmented,0.2711864406779661,train
DB00352,Tioguanine,DBMET01157,Thiodeoxyguanosine triphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)c2[nH]1,DB00352,DrugBank Augmented,0.217391304347826,train
DB00455,Loratadine,DBMET02792,3-hydroxydesloratadine glucuronide,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,O=C(O)C1OC(Oc2cnc3c(c2)CCc2cc(Cl)ccc2C3=C2CCNCC2)C(O)C(O)C1O,DB00455,DrugBank Augmented,0.3703703703703703,train
DB00461,Nabumetone,DBMET02525,6-hydroxy-naphthylacetic acid glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,O=C(Cc1ccc2cc(O)ccc2c1)OC1OC(C(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented,0.2586206896551724,train
DB00461,Nabumetone,DBMET02532,reduced O-desmethyl-3-hydroxy-nabumetone glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.3050847457627119,train
DB00461,Nabumetone,DBMET02539,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated) glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.3125,train
DB00461,Nabumetone,DBMET02542,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated) glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(CCc1ccc2cc(O)ccc2c1)OC1OC(C(=O)NCC(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented,0.2686567164179104,train
DB00476,Duloxetine,DBMET00750,"5-hydroxy, 6-methoxy duloxetine sulfate",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(OS(=O)(=O)O)c(OC)ccc12)c1ccco1,DB00476,DrugBank Augmented,0.390625,train
DB00476,Duloxetine,DBMET02509,"5-hydroxy, 6-methoxy duloxetine glucuronide",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(OC3OC(C(=O)O)C(O)C(O)C3O)c(OC)ccc12)c1cccs1,DB00476,DrugBank Augmented,0.5,train
DB00582,Voriconazole,DBMET01187,Voriconazole O-glucuronide derivative (1),CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,O=C(O)C1OC(Oc2ccc(C(O)Cn3cncn3)c(F)c2)C(O)C(O)C1O,DB00582,DrugBank Augmented,0.2839506172839506,train
DB00675,Tamoxifen,DBMET02716,Tamoxifen Metabolite E,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(O)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.5384615384615384,train
DB00997,Doxorubicin,DBMET03629,Demethyldeoxaglycone doxorubicinol 4-O-sulfate,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(OS(=O)(=O)O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented,0.3296703296703296,train
DB00997,Doxorubicin,DBMET03630,Demethyldeoxaglycone doxorubicinol 4-O-b-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(OC3OC(C(=O)O)C(O)C(O)C3O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented,0.375,train
DB01026,Ketoconazole,DBMET02663,M2 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CNC(=O)CNC=O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.6385542168674698,train
DB01026,Ketoconazole,DBMET02664,M5 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C(=O)CNC4=O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.717948717948718,train
DB01026,Ketoconazole,DBMET02668,M4 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,CC(=O)N1CCN(c2ccc(OCC3COC(CN)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,DrugBank Augmented,0.7361111111111112,train
DB00322,Floxuridine,DBMET03587,5-fluorodeoxyuridine diphosphate (5-FdUDP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)OP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented,0.6538461538461539,train
DB01275,Hydralazine,DBMET02824,Triazolophthalazine,NNc1nncc2ccccc12,c1ccc2c(c1)cnn1cnnc21,DB01275,DrugBank Augmented,0.3684210526315789,train
DB01283,Lumiracoxib,DBMET01286,Lumiracoxib metabolite M2,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(C(=O)O)ccc1Nc1c(F)cc(OS(=O)(=O)O)cc1Cl,DB01283,DrugBank Augmented,0.4576271186440678,train
DB01283,Lumiracoxib,DBMET01287,Lumiracoxib metabolite M8,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)c1ccc2c(c1)CC(=O)N2c1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented,0.2058823529411764,train
DB08882,Linagliptin,DBMET02392,Linagliptin M504(2),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(NCCCC(=O)C(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DB08882,DrugBank Augmented,0.5714285714285714,train
DB08912,Dabrafenib,DBMET03513,M31-Dabrafenib,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,C=C(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,DB08912,DrugBank Augmented,0.7272727272727273,train
DB08912,Dabrafenib,DBMET03514,M30-Dabrafenib,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,Nc1nccc(-c2sc(C(CO)C(=O)O)nc2-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)n1,DB08912,DrugBank Augmented,0.6857142857142857,train
DB09081,Idebenone,DBMET01524,QS4,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,COC1=C(OC)C(=O)C(CCCCO)=C(C)C1=O,DB09081,DrugBank Augmented,0.9655172413793104,train
DB11637,Delamanid,DBMET01971,(S)-DM-6717,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=O)NC1=O,DB11637,DrugBank Augmented,0.5526315789473685,train
DB00461,Nabumetone,DBMET02533,reduced O-desmethyl-3-hydroxy-nabumetone glucuronide glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented,0.2727272727272727,train
DB00675,Tamoxifen,DBMET02717,Tamoxifen Metabolite E Glucuronide,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,DB00675,DrugBank Augmented,0.4629629629629629,train
DB00322,Floxuridine,DBMET03588,5-fluorodeoxyuridine triphosphate (5-FdUTP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented,0.6296296296296297,train
DB00322,Floxuridine,DBMET03592,5-FUDP-hexose,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OC3C(O)CC(O)C(O)C3CO)C(O)C2O)cc1F,DB00322,DrugBank Augmented,0.4477611940298507,train
DB08882,Linagliptin,DBMET02393,Linagliptin M476(1),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(NCCCC(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DB08882,DrugBank Augmented,0.5662650602409639,train
,tamoxifen,,"3,4-Dihydroxy-Tamoxifen",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCN(C)C)cc1)c1ccc(O)c(O)c1)c1ccccc1,tamoxifen,MetXBioDB Augmented,0.813953488372093,train
,codeine,,Normorphine,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,Oc1ccc2c3c1OC1C(O)C=CC4C(CNCC341)C2,codeine,MetXBioDB Augmented,0.4444444444444444,train
,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",,2-hydroxyestradiol,COc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4cc(O)c(O)cc4CCC3C1CCC2O,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",MetXBioDB Augmented,0.6530612244897959,train
,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",,,COc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4ccc(O)c(O)c4CCC3C1CCC2O,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",MetXBioDB Augmented,0.5769230769230769,train
,(R)-mianserin,,"(R)-mianserin, 8-OH-N-desmethyl",CN1CCN2c3ccccc3Cc3ccccc3C2C1,Oc1ccc2c(c1)N1CCNCC1c1ccccc1C2,(R)-mianserin,MetXBioDB Augmented,0.42,train
,Chlorpyrifos,,"3,5,6-Trichloro-2-pyridinol",CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl,Oc1nc(Cl)c(Cl)cc1Cl,Chlorpyrifos,MetXBioDB Augmented,0.3333333333333333,train
,Chlorpyrifos,,Diethyl phosphate,CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl,CCOP(=O)(O)OCC,Chlorpyrifos,MetXBioDB Augmented,0.2162162162162162,train
,Diazinon,,Pyrimidinol,CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1,Cc1cc(O)nc(C(C)C)n1,Diazinon,MetXBioDB Augmented,0.4,train
,Encainide,,"N,O-didemethylencainide",COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1,O=C(Nc1ccccc1CCC1CCCCN1)c1ccc(O)cc1,Encainide,MetXBioDB Augmented,0.5166666666666667,train
,hydrocodone,,Norhydromorphone,COc1ccc2c3c1OC1C(=O)CCC4C(C2)N(C)CCC314,O=C1CCC2C3Cc4ccc(O)c5c4C2(CCN3)C1O5,hydrocodone,MetXBioDB Augmented,0.4761904761904761,train
,Methoxychlor,,Catechol-methoxychlor,COc1ccc(C(c2ccc(OC)cc2)C(Cl)(Cl)Cl)cc1,COc1ccc(C(c2ccc(O)c(O)c2)C(Cl)(Cl)Cl)cc1,Methoxychlor,MetXBioDB Augmented,0.7096774193548387,train
,Methoxychlor,,Bis-OH-methoxychlor,COc1ccc(C(c2ccc(OC)cc2)C(Cl)(Cl)Cl)cc1,Oc1ccc(C(c2ccc(O)cc2)C(Cl)(Cl)Cl)cc1,Methoxychlor,MetXBioDB Augmented,0.5185185185185185,train
,mifepristone,,Didemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N)cc3)CC21C,mifepristone,MetXBioDB Augmented,0.8253968253968254,train
,Methoxychlor,,Tris-OH-methoxychlor,COc1ccc(C(c2ccc(OC)cc2)C(Cl)(Cl)Cl)cc1,Oc1ccc(C(c2ccc(O)c(O)c2)C(Cl)(Cl)Cl)cc1,Methoxychlor,MetXBioDB Augmented,0.4117647058823529,train
,tamoxifen,,alpha-OH-N-desmethyltamoxifen,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CNCCOc1ccc(C(=C(c2ccccc2)C(C)O)c2ccccc2)cc1,tamoxifen,MetXBioDB Augmented,0.42,train
,Verapamil,,D-715 (PR-22),COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1cc(CCNCCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)ccc1O,Verapamil,MetXBioDB Augmented,0.6229508196721312,train
,Verapamil,,"2-(3,4-dimethoxyphenyl)acetaldehyde",COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(CC=O)cc1OC,Verapamil,MetXBioDB Augmented,0.3148148148148148,train
,sulfinpyrazone_sulfide,,Sulfinpyrazone sulfone,O=C1C(CCSc2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,O=C1C(CCS(=O)(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,sulfinpyrazone_sulfide,MetXBioDB Augmented,0.525,train
,OXODIPINE,,OXODIPINE(m2),CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc2c1OCO2,CCOC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1cccc2c1OCO2,OXODIPINE,MetXBioDB Augmented,0.4444444444444444,train
,warfarin-r,,Warfarin 8-O-glucuronide,CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O,CC(=O)CC(c1ccccc1)c1c(O)c2cccc(OC3OC(C(=O)O)C(O)C(O)C3O)c2oc1=O,warfarin-r,MetXBioDB Augmented,0.417910447761194,train
,warfarin-s,,Warfarin 7-O-glucuronide,CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O,CC(=O)CC(c1ccccc1)c1c(O)c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc2oc1=O,warfarin-s,MetXBioDB Augmented,0.4117647058823529,train
,warfarin-r,,Warfarin 6-O-glucuronide,CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O,CC(=O)CC(c1ccccc1)c1c(O)c2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2oc1=O,warfarin-r,MetXBioDB Augmented,0.4328358208955223,train
,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",,Estradiol 2-O-glucuronide,COc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4cc(OC5OC(C(=O)O)C(O)C(O)C5O)c(O)cc4CCC3C1CCC2O,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",MetXBioDB Augmented,0.4852941176470588,train
,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",,2-O-methoxyestradiol,COc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,COc1cc2c(cc1O)CCC1C2CCC2(C)C(O)CCC12,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",MetXBioDB Augmented,0.6730769230769231,train
,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",,3-O-methoxyestradiol,COc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,COc1cc2c(cc1O)C1CCC3(C)C(O)CCC3C1CC2,"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",MetXBioDB Augmented,0.6730769230769231,train
,Gavestinel,,gavestinel 4-sulfate,O=C(C=Cc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1,O=C(C=Cc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccc(OS(=O)(=O)O)cc1,Gavestinel,MetXBioDB Augmented,0.7592592592592593,train
,8-hydroxyefavirenz,,,OC1=Nc2c(O)cc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,O=C(O)C1OC(OC2(C#CC3(C(F)(F)F)OC(O)=Nc4c(O)cc(Cl)cc43)CC2)C(O)C(O)C1O,8-hydroxyefavirenz,MetXBioDB Augmented,0.5522388059701493,train
,aceclofenac,,,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)OC1OC(C(=O)O)C(O)C(O)C1O,aceclofenac,MetXBioDB Augmented,0.5454545454545454,train
,Buprenorphine,,,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(O)c5c4C3(CCN1CC1CC1)C2O5,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(OC5OC(C(=O)O)C(O)C(O)C5O)c5c4C3(CCN1)C2O5,Buprenorphine,MetXBioDB Augmented,0.4673913043478261,train
,O-isopropyl acetaminophen,,,CC(=O)Nc1ccc(OC(C)C)cc1,CC(=O)Nc1ccc(OS(=O)(=O)O)cc1,O-isopropyl acetaminophen,MetXBioDB Augmented,0.5454545454545454,train
,O-isopropyl acetaminophen,,,CC(=O)Nc1ccc(OC(C)C)cc1,CC(=O)Nc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1,O-isopropyl acetaminophen,MetXBioDB Augmented,0.4090909090909091,train
,codeine,,,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(O)C=CC3C1C5,codeine,MetXBioDB Augmented,0.6666666666666666,train
,formononetin,,,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1,O=C(O)C1OC(Oc2ccc3c(=O)c(-c4ccc(O)cc4)coc3c2)C(O)C(O)C1O,formononetin,MetXBioDB Augmented,0.5172413793103449,train
,diclofenac,,,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)Cc1cc(OC2OC(C(=O)O)C(O)C(O)C2O)ccc1Nc1c(Cl)cccc1Cl,diclofenac,MetXBioDB Augmented,0.4629629629629629,train
,diclofenac,,,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)Cc1cc(OS(=O)(=O)O)ccc1Nc1c(Cl)cccc1Cl,diclofenac,MetXBioDB Augmented,0.5681818181818182,train
,hydrocodone,,Hydromorphone 3-beta-O-glucuronide,COc1ccc2c3c1OC1C(=O)CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(=O)CCC3C1C5,hydrocodone,MetXBioDB Augmented,0.6617647058823529,train
,hydrocodone,,Hydromorphone 3-sulfate,COc1ccc2c3c1OC1C(=O)CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OS(=O)(=O)O)c4OC2C(=O)CCC3C1C5,hydrocodone,MetXBioDB Augmented,0.7758620689655172,train
,harmine,,,COc1ccc2c(c1)[nH]c1c(C)nccc12,Cc1nccc2c1[nH]c1cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc12,harmine,MetXBioDB Augmented,0.5272727272727272,train
,harmine,,,COc1ccc2c(c1)[nH]c1c(C)nccc12,Cc1nccc2c1[nH]c1cc(OS(=O)(=O)O)ccc12,harmine,MetXBioDB Augmented,0.6904761904761905,train
,nevirapine,,,Cc1ccnc2c1N=C(O)c1cccnc1N2C1CC1,Cc1c(OC2OC(C(=O)O)C(O)C(O)C2O)cnc2c1N=C(O)c1cccnc1N2C1CC1,nevirapine,MetXBioDB Augmented,0.5151515151515151,train
,galantamine,,,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(OC4OC(C(=O)O)C(O)C(O)C4O)ccc(c23)C1,galantamine,MetXBioDB Augmented,0.676923076923077,train
,aceclofenac,,,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)COC(=O)Cc1cc(OC2OC(C(=O)O)C(O)C(O)C2O)ccc1Nc1c(Cl)cccc1Cl,aceclofenac,MetXBioDB Augmented,0.5409836065573771,train
,aceclofenac,,,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,O=C(O)COC(=O)Cc1cc(OS(=O)(=O)O)ccc1Nc1c(Cl)cccc1Cl,aceclofenac,MetXBioDB Augmented,0.6470588235294118,train
,schembl29464,,,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,O=C(O)C1OC(OC2N=C(c3ccccc3)c3cc(Cl)ccc3N=C2O)C(O)C(O)C1O,schembl29464,MetXBioDB Augmented,0.3623188405797101,train
,Phenobarbital,,,CCC1(c2ccccc2)C(O)=NC(=O)N=C1O,CCC1(c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc2)C(O)=NC(=O)N=C1O,Phenobarbital,MetXBioDB Augmented,0.4901960784313725,train
,Phenobarbital,,,CCC1(c2ccccc2)C(O)=NC(=O)N=C1O,CCC1(c2ccc(OS(=O)(=O)O)cc2)C(O)=NC(=O)N=C1O,Phenobarbital,MetXBioDB Augmented,0.6,train
,(s)-flurbiprofen,,,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,CC(C(=O)O)c1ccc(-c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc2)c(F)c1,(s)-flurbiprofen,MetXBioDB Augmented,0.5384615384615384,train
,formononetin,,Dihydrodazein,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1,O=C1c2ccc(O)cc2OCC1c1ccc(O)cc1,formononetin,MetXBioDB Augmented,0.2363636363636363,train
,"3,4-dihydroxyphenylacetic acid",,2-Phenylacetic acid,O=C(O)Cc1ccc(O)c(O)c1,O=C(O)Cc1ccccc1,"3,4-dihydroxyphenylacetic acid",MetXBioDB Augmented,0.5,train
,Genistein,,,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,C=C(C(=O)c1c(O)cc(O)cc1O)c1ccc(O)cc1,Genistein,MetXBioDB Augmented,0.3181818181818182,train
,Genistein,,6'-Hydroxy-O-desmethylangolensin,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,CC(C(=O)c1c(O)cc(O)cc1O)c1ccc(O)cc1,Genistein,MetXBioDB Augmented,0.2826086956521739,train
,Genistein,,4-hydroxyphenyl-2-propenoic acid,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,C=C(C(=O)O)c1ccc(O)cc1,Genistein,MetXBioDB Augmented,0.238095238095238,train
,Genistein,,Phloroglucinol,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Oc1cc(O)cc(O)c1,Genistein,MetXBioDB Augmented,0.2121212121212121,train
,Genistein,,,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,CC(C(=O)O)c1ccc(O)cc1,Genistein,MetXBioDB Augmented,0.2045454545454545,train
